≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other acquired deformities of musculoskeletal system and connective tissue

DOID EFO Endpoint Browser PheWeb

M13_DEFORMACQ

musculoskeletal system disease: A disease involving the musculoskeletal system. [database_cross_reference: MONDO:DesignPattern]

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M95
  • Hospital discharge: ICD-9 — 738
  • Hospital discharge: ICD-8 — 7380[8-9]
  • Cause of death: ICD-10 — M95
  • Cause of death: ICD-9 — 738
  • Cause of death: ICD-8 — 7380[8-9]

2 out of 7 registries used, show all original rules.

1845

4. Check minimum number of events

None

1845

5. Include endpoints

None

1845

6. Filter based on genotype QC (FinnGen only)

1749

Control definitions (FinnGen only)

Control exclude
M13_MUSCULOSKELEOTH

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M95-M99
Name in latin
Aliae deformitates acquisitae systematis musculosceletalis et textus connectivi

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 14910 6894 7861
Only index persons 13114 6054 7060
Unadjusted period prevalence (%)
Whole population 0.21 0.20 0.22
Only index persons 0.25 0.22 0.27
Median age at first event (years)
Whole population 38.29 40.56 36.21
Only index persons 36.64 38.52 35.04

-FinnGen-

Key figures

All Female Male
Number of individuals 1749 900 849
Unadjusted period prevalence (%) 0.35 0.32 0.39
Median age at first event (years) 40.12 38.74 41.60

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1845
Matched controls
18450
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J34.2
ICD-10 Finland
Deviated nasal septum
10.6
307.7
454
552
M95.0
ICD-10 Finland
Acquired deformity of nose
2755.5
307.7
874
6
73808
ICD-8 Finland
Other deformities, Aliae definitae
+∞
307.7
358
*
DLD20
NOMESCO Finland
Rhinoplasty
780.5
279.0
268
*
DLD10
NOMESCO Finland
Reconstruction of cartilage and bone of nose
1363.8
249.8
238
*
DJD20
NOMESCO Finland
Plastic repair of septum of nose
10.1
239.1
294
341
DLD00
NOMESCO Finland
Reconstruction of cartilage of nose
105.0
228.8
118
12
7384A
ICD-9 Finland
Other acquired deformity, Acquired spondylolisthesis
+∞
197.5
186
*
73809
ICD-8 Finland
Other deformities, Unspecified
+∞
157.6
149
*
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
12.2
157.3
162
144
M95.8
ICD-10 Finland
Other specified acquired deformities of musculoskeletal system
+∞
93.5
89
*
DHD10
NOMESCO Finland
Closed reduction of fracture of nose
17.7
91.5
75
44
DHB50
NOMESCO Finland
Turbinoplasty
6.3
73.0
128
217
ZZG00
NOMESCO Finland
Graft of cartilage
90.5
70.5
78
9
7380A
ICD-9 Finland
Other acquired deformity, Acquired deformity of nose
+∞
61.8
59
*
9183
FHL
Posterolateral spondylodesis
114.0
61.2
66
6
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
56.8
585
3075
7385A
ICD-9 Finland
Other acquired deformity of back or spine
+∞
52.3
50
*
73799
ICD-8 Finland
Hallux valgus and varus
7.0
49.8
77
114
N02AX02
ATC
tramadol; systemic, rectal
2.0
48.0
901
5886
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
47.8
733
4449
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
5.5
44.1
88
168
M95.9
ICD-10 Finland
Acquired deformity of musculoskeletal system, unspecified
+∞
41.8
40
*
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
7.5
39.5
57
78
4211
FHL
Transeptal septal resection and reconstruction
10.2
39.0
44
44
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.0
37.2
182
659
ZXB10
NOMESCO Finland
Medial
12.7
35.8
35
28
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
34.3
717
4704
9212
FHL
Other posterior root decompression surgery (eg laminectomy, Gill)
11.5
32.7
34
30
M43.1
ICD-10 Finland
Spondylolisthesis
3.6
32.0
111
326
N03AX16
ATC
[U] pregabalin
2.0
31.6
471
2755
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
31.3
871
6179
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
28.4
692
4688
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
28.2
277
1385
4700A
ICD-9 Finland
Deflected nasal septum[DEFORMATIO SEPTI NASI]
6.0
27.8
49
83
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.7
27.5
89
249
R01AD09
ATC
mometasone; nasal
1.7
27.3
863
6264
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.3
27.3
227
1060
J31.0
ICD-10 Finland
Chronic rhinitis
2.4
26.7
200
892
2309
FHL
Other measure in this category
52.5
26.3
31
6
ZXE00
NOMESCO Finland
One hour or less
1.7
25.9
706
4901
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
25.7
401
2361
A02BC05
ATC
esomeprazole; systemic
1.7
25.7
766
5446
R01AD08
ATC
fluticasone; nasal
1.7
24.0
543
3567
N06AA09
ATC
amitriptyline; systemic
2.3
23.9
197
915
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
23.9
836
6163
N03AX12
ATC
[U] gabapentin; oral
1.9
23.3
322
1816
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
23.1
876
6570
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.2
22.7
198
940
M95.4
ICD-10 Finland
Acquired deformity of chest and rib
232.8
22.7
23
*
M79.6
ICD-10 Finland
Pain in limb
1.6
22.6
832
6181
J01DB01
ATC
cefalexin; oral
1.9
22.4
1530
13315
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
22.4
147
616
75618
ICD-8 Finland
Other congenital anomalies of musculoskeletal system, Maleformationes columnae vertebralis aliae
18.2
22.2
34
19
N06AX21
ATC
duloxetine; oral
2.0
22.2
252
1326
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
22.0
308
1743
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
8.2
21.8
29
36
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.1
21.4
224
1142
DLW99
NOMESCO Finland
Other plastic operations on nose
43.9
21.4
26
6
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
20.8
268
1472
R03AC02
ATC
salbutamol; inhalant
1.6
20.8
1004
7906
4204
FHL
Molding of the cartilaginous part of the nose
111.3
20.6
22
*
R06.0
ICD-10 Finland
Dyspnoea
1.7
20.5
505
3369
N06AX11
ATC
mirtazapine; oral
1.6
20.4
637
4516
M43.0
ICD-10 Finland
Spondylolysis
4.3
20.3
53
127
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
20.2
653
4667
M54.5
ICD-10 Finland
Low back pain
1.6
20.0
694
5041
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
4.9
19.9
44
92
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
8.2
19.7
26
32
M02AA07
ATC
piroxicam; topical
1.6
19.6
634
4523
WX704
NOMESCO Finland
Intubation
2.2
19.5
169
799
ZXA10
NOMESCO Finland
Bilateral
1.8
19.5
325
1938
X58
ICD-10 Finland
Exposure to other specified factors
1.8
19.1
308
1817
WX402
NOMESCO Finland
General anaesthesia
1.7
18.9
423
2742
4203
FHL
Mobilization and repositioning of the external pyramid
34.7
18.9
24
7
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
18.9
754
5638
H02AB06
ATC
prednisolone; systemic
1.6
18.9
851
6542
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.8
18.6
93
340
A02BC02
ATC
pantoprazole; systemic
1.6
18.5
1241
10407
50499
ICD-8 Finland
Deflected nasal septum
4.5
18.5
45
102
M01AB05
ATC
diclofenac; systemic, rectal
1.6
18.3
1214
10140
L01BA01
ATC
methotrexate; systemic
3.0
18.2
81
277
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
5.7
18.2
34
61
ZXC60
NOMESCO Finland
Application of heat
4.2
18.2
48
116
WX002
NOMESCO Finland
Sedation and analgesia
1.8
18.2
347
2150
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
18.1
287
1683
N02BF02
ATC
pregabalin; oral
2.3
18.1
145
664
N05CF02
ATC
zolpidem; oral
1.8
18.1
334
2050
N06AX16
ATC
venlafaxine; oral
1.8
18.1
280
1630
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.0
18.0
219
1177
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
17.9
123
526
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
17.7
525
3649
N05CF01
ATC
zopiclone; oral
1.6
17.7
563
3982
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
96.0
17.6
19
*
N06AB04
ATC
citalopram; systemic
1.7
17.5
371
2364
L28
ICPC
Limited function/disability (L)
1.7
17.5
336
2084
A02BC01
ATC
omeprazole; systemic
1.6
17.3
464
3146
R06.5
ICD-10 Finland
Mouth breathing
2.0
17.1
193
1010
M48.0
ICD-10 Finland
Spinal stenosis
1.9
17.1
228
1264
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
17.1
515
3590
ZXD20
NOMESCO Finland
Day surgery
1.9
16.9
239
1349
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
16.9
185
958
ZXA05
NOMESCO Finland
Left side
1.7
16.8
423
2818
N05BA04
ATC
oxazepam; oral
1.6
16.6
461
3145
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
16.6
400
2634
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
16.5
1299
11133
R02
ICPC
Shortness of breath/dyspnoea
1.8
16.1
249
1445
M01AH05
ATC
etoricoxib; oral
1.5
16.1
1150
9620
N05AH04
ATC
quetiapine; oral
1.7
16.0
331
2092
R08
ICPC
Nose symptom/complaint other
2.8
16.0
82
304
L17
ICPC
Foot/toe symptom/complaint
1.6
15.8
542
3879
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
15.8
347
2228
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
15.6
480
3350
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
15.6
207
1145
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.1
15.5
153
762
N02BE01
ATC
paracetamol; systemic, rectal
1.8
15.4
1622
14767
H02AB07
ATC
prednisone; oral
1.8
15.3
242
1414
M25.5
ICD-10 Finland
Pain in joint
1.5
15.3
613
4537
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
15.1
556
4034
4202
FHL
Forming an external pyramid without mobilization
23.6
15.1
21
9
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
15.1
181
967
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.2
14.9
135
649
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.2
14.9
129
609
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
14.9
201
1116
R01AD12
ATC
fluticasone furoate; nasal
1.5
14.9
558
4064
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
14.8
246
1459
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.9
14.7
69
244
J01AA02
ATC
doxycycline; systemic
1.6
14.7
1379
12097
9189
FHL
Other measure in this category
+∞
14.6
14
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
14.6
119
549
R52.2
ICD-10 Finland
Other chronic pain
2.6
14.5
84
331
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.4
14.5
99
423
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
5.2
14.4
29
56
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
2.6
14.4
86
345
7225B
ICD-9 Finland
Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]
17.1
14.3
22
13
M01CB01
ATC
sodium aurothiomalate; parenteral
4.6
14.3
33
72
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.0
14.2
161
842
M20.5
ICD-10 Finland
Other deformities of toe(s) (acquired)
6.2
14.2
24
39
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
14.2
346
2277
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
3.6
14.1
46
130
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
13.9
450
3165
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
6.1
13.9
24
40
R52.9
ICD-10 Finland
Pain, unspecified
1.9
13.7
198
1123
N02BF01
ATC
gabapentin; oral
1.8
13.7
200
1138
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.6
13.7
45
128
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
13.6
138
693
M20.1
ICD-10 Finland
Hallux valgus (acquired)
2.0
13.6
150
777
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.2
13.6
113
525
M01AX17
ATC
nimesulide; oral
1.6
13.5
410
2839
7561A
ICD-9 Finland
Other congenital musculoskeletal anomalies, Anomalies of spine[SPONDYLOLISTHESIS CONGENITA]
34.3
13.5
17
5
A02BC03
ATC
lansoprazole; oral
1.5
13.4
490
3534
AA1AD
NOMESCO Finland
CT of head and brain
1.5
13.4
496
3587
TQW40
NOMESCO Finland
Remowal of suture of skin
2.1
13.4
138
697
N05BA01
ATC
diazepam; systemic, rectal
1.8
13.4
233
1398
A01AB09
ATC
miconazole; local oral
2.0
13.4
155
817
M03BX02
ATC
tizanidine; oral
1.5
13.3
1115
9450
L88
ICPC
Rheumatoid/seropositive arthritis
2.5
13.3
83
340
R06AE07
ATC
cetirizine; oral
1.5
13.3
752
5923
S21
ICPC
Skin texture symptom/complaint
1.7
13.2
262
1631
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
13.2
335
2223
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
4.8
13.1
29
61
R53
ICD-10 Finland
Malaise and fatigue
1.5
13.1
440
3117
Z3226
NOMESCO Finland
Physiotherapist
1.6
13.0
308
2007
1220
FHL
Arthroscopy
2.5
12.9
83
345
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.1
12.9
54
179
73805
ICD-8 Finland
Other deformities, Digitus malleus
14.1
12.8
21
15
J01MA02
ATC
ciprofloxacin; systemic
1.5
12.7
658
5084
M54.8
ICD-10 Finland
Other dorsalgia
2.4
12.6
90
392
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
12.6
396
2759
L12
ICPC
Hand/finger symptom/complaint
1.6
12.6
309
2033
M96.0
ICD-10 Finland
Pseudarthrosis after fusion or arthrodesis
+∞
12.5
12
*
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.8
12.5
37
98
J01DA01
ATC
[U] cefalexin
1.4
12.5
1063
8986
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
12.5
716
5635
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
2.8
12.4
62
227
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
12.4
258
1626
R51.80
ICD-10 Finland
Headache
1.7
12.4
277
1779
N07BA03
ATC
varenicline; oral
2.2
12.3
103
481
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
12.2
188
1087
M19.2
ICD-10 Finland
Other secondary arthrosis
4.0
12.2
34
86
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.7
12.2
66
252
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.1
12.1
124
625
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
6.1
12.1
21
35
T74.1
ICD-10 Finland
Physical abuse
3.2
12.1
47
149
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
12.1
382
2664
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.5
12.0
73
295
J01FF01
ATC
clindamycin; systemic
1.5
12.0
466
3392
Z2221
NOMESCO Finland
Medical doctor
1.5
12.0
450
3254
N06AB03
ATC
fluoxetine; oral
1.7
12.0
213
1286
L04AX03
ATC
methotrexate; systemic
1.8
11.9
176
1006
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
11.9
223
1366
R42
ICD-10 Finland
Dizziness and giddiness
1.5
11.8
384
2693
A06AD11
ATC
lactulose; oral
1.7
11.8
239
1495
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
11.8
243
1528
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.6
11.7
66
258
SBB10
NOMESCO Finland
Dental impressions
2.0
11.5
123
630
WX320
NOMESCO Finland
Spinalanesthesy
1.5
11.5
405
2888
ZXD05
NOMESCO Finland
Urgent procedure
1.5
11.4
492
3653
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
11.4
1164
10081
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.9
11.4
144
783
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.0
11.3
134
712
R03AC03
ATC
terbutaline; inhalant
1.7
11.3
236
1488
L04AA13
ATC
[U] leflunomide
2.9
11.3
51
177
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.3
11.3
83
367
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.2
11.3
97
458
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.1
11.3
104
505
L08
ICPC
Shoulder symptom/complaint
1.5
11.2
410
2944
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.8
11.2
57
211
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
11.1
1632
15146
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
3.0
11.1
47
157
S18
ICPC
Laceration/cut
1.4
11.1
807
6582
S00.3
ICD-10 Finland
Superficial injury of nose
4.2
11.1
29
70
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
11.0
622
4855
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
11.0
195
1176
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.7
10.9
60
231
L02
ICPC
Back symptom/complaint
1.7
10.9
191
1147
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
10.9
803
6559
9165
FHL
Removal of osteosynthesis material
3.0
10.8
46
154
R96
ICPC
Asthma
1.8
10.8
171
997
Z01.2
ICD-10 Finland
Dental examination
1.4
10.8
799
6527
A02BA02
ATC
ranitidine; systemic
1.6
10.8
310
2111
A97
ICPC
No disease
1.5
10.8
334
2313
J02AC01
ATC
fluconazole; systemic
1.4
10.7
611
4771
A01
ICPC
Pain general/multiple sites
1.8
10.7
183
1092
N06AB10
ATC
escitalopram; oral
1.5
10.7
347
2428
9279
FHL
Other measure in this category
13.0
10.6
18
14
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.3
10.6
76
332
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
10.6
955
8049
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.8
10.6
54
200
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
4.7
10.5
24
52
A29
ICPC
General symptom/complaint other
1.6
10.4
230
1469
S02.40
ICD-10 Finland
Fracture of malar and maxillary bones, closed
3.7
10.4
32
87
7228C
ICD-9 Finland
Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]
+∞
10.4
10
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
10.4
905
7577
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
10.4
493
3718
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.2
10.3
41
132
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
10.3
469
3509
UDM02
NOMESCO Finland
Sinoscopy
2.9
10.3
48
170
R4120
NOMESCO Finland
Occupational therapy
2.0
10.2
118
622
R4110
NOMESCO Finland
Physiotherapy
1.5
10.2
464
3470
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
10.2
498
3774
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.1
10.2
92
443
N03AE01
ATC
clonazepam; systemic
2.1
10.2
102
511
D06
ICPC
Abdominal pain localized other
1.8
10.1
144
813
M01AX01
ATC
nabumetone; oral
2.3
10.1
75
333
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
10.1
409
2991
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
10.0
89
427
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.9
9.9
118
630
XKC03
NOMESCO Finland
Water cystometry
2.6
9.9
55
214
J01MA12
ATC
levofloxacin; systemic
1.5
9.8
299
2059
P01BA02
ATC
hydroxychloroquine; oral
1.9
9.8
135
754
S01.2
ICD-10 Finland
Open wound of nose
3.4
9.7
34
101
ZXA00
NOMESCO Finland
Right side
1.5
9.7
422
3124
W19
ICD-10 Finland
Unspecified fall
1.7
9.7
170
1021
A07EC01
ATC
sulfasalazine; oral, rectal
1.8
9.7
138
780
N02AC04
ATC
dextropropoxyphene; oral
2.5
9.7
61
252
N29
ICPC
Neurological sympt/complt other
3.1
9.7
39
127
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.8
9.7
162
961
R03BA01
ATC
beclometasone; inhalant
1.6
9.6
226
1465
R01AD58
ATC
fluticasone, combinations; nasal
1.5
9.6
422
3130
M01AB55
ATC
diclofenac, combinations; oral
2.0
9.6
110
578
WX400
NOMESCO Finland
Inhalation anesthesy
2.3
9.6
74
334
SPAT1153
SPAT
Removal of sutures
1.4
9.6
497
3799
C07AA05
ATC
propranolol; systemic
1.5
9.6
332
2349
M01AE02
ATC
naproxen; oral, rectal
1.4
9.6
965
8226
M01AH02
ATC
rofecoxib; oral
1.7
9.5
203
1285
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
9.5
299
2075
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.1
9.5
84
402
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.4
9.4
61
255
M13.9
ICD-10 Finland
Arthritis, unspecified
1.8
9.4
130
727
9181
FHL
Anterior spondylodesis
+∞
9.4
9
*
9193
FHL
Spondylodesis (also includes correction)
+∞
9.4
9
*
S02.21
ICD-10 Finland
Fracture of nasal bones, open
12.4
9.4
16
13
R13
ICD-10 Finland
Dysphagia
1.9
9.3
124
686
9272
FHL
Metatarsophalangeal joint resection
10.7
9.3
17
16
WX725
NOMESCO Finland
Noninvasive ventilation
2.0
9.3
103
536
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
9.3
1255
11183
A92
ICPC
Allergy/allergic reaction NOS
2.5
9.2
55
221
R07.0
ICD-10 Finland
Pain in throat
1.9
9.2
119
651
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.8
9.2
130
732
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
2.8
9.2
46
169
UKC02
NOMESCO Finland
Cystoscopy
1.6
9.2
240
1595
Z3231
NOMESCO Finland
Registered nurse
1.4
9.2
433
3251
SFA10
NOMESCO Finland
One-surface restoration
1.4
9.2
944
8051
XKD00
NOMESCO Finland
Uroflowmetry
1.6
9.2
223
1458
R21
ICPC
Throat symptom/complaint
1.5
9.2
325
2310
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.5
9.2
56
228
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
2.9
9.1
43
153
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
9.0
147
864
L03
ICPC
Low back symptom/complaint
1.4
9.0
489
3762
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.8
9.0
125
700
N05CD07
ATC
temazepam; oral
1.7
9.0
181
1128
A02BA04
ATC
nizatidine; systemic
1.9
9.0
122
679
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
9.0
80
384
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
8.9
383
2824
7373A
ICD-9 Finland
Curvature of spine, Kyphoscoliosis and scoliosis
24.1
8.9
12
5
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
8.9
317
2255
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.6
8.9
49
190
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
8.9
655
5302
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.6
8.8
51
202
S06.0
ICD-10 Finland
Concussion
1.6
8.8
186
1174
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.6
8.8
197
1262
G47.3
ICD-10 Finland
Sleep apnoea
1.4
8.8
417
3132
K59.09
ICD-10 Finland
Constipation, unspecified
1.9
8.8
112
611
S02.2
ICD-10 Finland
Fracture of nasal bones
9.5
8.8
17
18
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
2.5
8.8
52
209
M54.2
ICD-10 Finland
Cervicalgia
1.7
8.7
147
873
7561D
ICD-9 Finland
Other congenital musculoskeletal anomalies, Anomalies of spine[SPONDYLOLYSIS CONGENITA]
50.2
8.7
10
*
J01CF02
ATC
cloxacillin; systemic
2.9
8.7
40
141
J01DA06
ATC
[U] cefuroxime
1.6
8.6
232
1552
K02.1
ICD-10 Finland
Caries of dentine
1.3
8.6
1013
8779
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
8.6
722
5950
M50.3
ICD-10 Finland
Other cervical disc degeneration
2.6
8.6
47
181
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
8.6
216
1422
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.5
8.6
54
223
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
8.6
200
1294
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.6
8.6
188
1198
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
8.3
8.6
18
22
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.7
8.6
164
1009
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.0
8.6
85
425
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
8.6
305
2168
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.7
8.6
174
1088
N07BB01
ATC
disulfiram; oral
2.1
8.5
83
412
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
3.5
8.5
29
85
A11
ICPC
Chest pain NOS
1.7
8.5
149
895
DHB45
NOMESCO Finland
Turbinate reduction
27.6
8.5
11
*
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
8.5
348
2543
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
8.4
206
1348
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
8.4
852
7220
8020A
ICD-9 Finland
Fracture of face bones, Nasal bones, closed
6.7
8.4
20
30
M96.6
ICD-10 Finland
Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate
+∞
8.3
8
*
7383A
ICD-9 Finland
Other acquired deformity, Acquired deformity of chest and rib
+∞
8.3
8
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
8.3
169
1057
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.4
8.3
55
233
Y07
ICD-10 Finland
Other maltreatment
4.1
8.3
22
54
R03DC03
ATC
montelukast; oral
1.5
8.3
272
1902
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.7
8.3
138
818
9102
FHL
Trepanation or removal of the local bone process
7.1
8.3
19
27
M01AH01
ATC
celecoxib; oral
1.5
8.2
288
2039
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.3
8.2
59
259
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
8.2
214
1422
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
8.1
61
273
M01AC06
ATC
meloxicam; systemic, rectal
1.4
8.1
598
4823
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
8.1
164
1024
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.6
8.1
179
1143
R06AX27
ATC
desloratadine; oral
1.4
8.1
469
3642
SAA04
NOMESCO Finland
Special examination of mouth
1.9
8.1
92
484
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
2.8
8.0
40
147
KMAK, ,
NOMESCO Finland
1.3
8.0
848
7208
R52.0
ICD-10 Finland
Acute pain
2.2
8.0
64
294
9229
FHL
Other measure in this category
22.1
8.0
11
5
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
8.0
186
1203
XKD03
NOMESCO Finland
Urethral pressure profilometry
2.8
8.0
39
142
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.4
8.0
497
3902
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
1.8
8.0
110
616
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
8.0
200
1317
L16
ICPC
Ankle symptom/complaint
1.6
7.9
198
1305
4212
FHL
Maxillapremmaxilla opening septum resection and reconstruction
6.1
7.8
20
33
M06
ICD-10 Finland
Other rheumatoid arthritis
6.1
7.8
20
33
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
3.0
7.8
34
116
P03
ICPC
Feeling depressed
1.7
7.8
159
994
S29
ICPC
Skin symptom/complaint other
1.4
7.8
325
2378
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.3
7.8
28
85
WX892
NOMESCO Finland
Monitored bed care
1.8
7.8
124
725
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
7.8
93
497
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.8
7.8
111
628
R35
ICD-10 Finland
Polyuria
1.8
7.8
108
606
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
2.2
7.8
62
285
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
7.7
393
2980
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
7.7
296
2132
UJF32
NOMESCO Finland
Coloscopy
1.4
7.7
408
3115
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
2.5
7.7
47
192
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
4.4
7.7
19
44
A04
ICPC
Weakness/tiredness general
1.5
7.7
250
1743
R03BA02
ATC
budesonide; inhalant
1.5
7.7
287
2058
B18.2
ICD-10 Finland
Chronic viral hepatitis C
3.4
7.7
27
81
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
7.6
266
1880
H02AB04
ATC
methylprednisolone; systemic
1.5
7.6
228
1561
G44.2
ICD-10 Finland
Tension-type headache
1.5
7.6
220
1495
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.7
7.6
156
978
NHG82
NOMESCO Finland
Fusion of other tarsal joint
3.6
7.6
24
67
P06
ICPC
Sleep disturbance
1.5
7.6
220
1498
M54.1
ICD-10 Finland
Radiculopathy
2.1
7.5
70
342
R05
ICPC
Cough
1.4
7.5
401
3064
SPAT1202
SPAT
Intra-articular injection
2.4
7.5
51
219
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
2.9
7.5
34
119
SFA20
NOMESCO Finland
Two-surface restoration
1.3
7.5
1000
8750
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
7.5
442
3436
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
7.5
199
1328
9254
FHL
Arthrotomy (includes biopsy, revision, loose removal, fixation, and similar procedures)
4.3
7.5
19
45
N06AA12
ATC
doxepin; systemic
1.9
7.4
85
448
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.7
7.4
128
767
R03BB04
ATC
tiotropium bromide; inhalant
1.6
7.4
153
962
Z71.8
ICD-10 Finland
Other specified counselling
1.3
7.4
551
4442
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
7.4
347
2596
7245A
ICD-9 Finland
Other and unspecified disorders of back, Backache, unspecified
3.8
7.4
22
59
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
7.3
315
2318
7388X
ICD-9 Finland
Other acquired deformity, Acquired deformity of other specified site
+∞
7.3
7
*
M95.2
ICD-10 Finland
Other acquired deformity of head
+∞
7.3
7
*
M95.5
ICD-10 Finland
Acquired deformity of pelvis
+∞
7.3
7
*
9807
FHL
Cartilage / perichondrium transfer
+∞
7.3
7
*
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.1
7.3
29
94
WX290
NOMESCO Finland
Other blockage of nerve
1.3
7.3
805
6855
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
7.3
263
1873
J01FA06
ATC
roxithromycin; oral
1.3
7.3
644
5320
9271
FHL
Hallux surgery
2.8
7.2
35
127
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.9
7.2
83
438
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
7.2
193
1289
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
7.1
133
813
R81
ICPC
Pneumonia
2.1
7.1
62
296
D11
ICPC
Diarrhoea
1.6
7.1
192
1286
R01AD05
ATC
budesonide; nasal
1.7
7.1
121
722
E8859
ICD-8 Finland
Fall on same level from slipping, stumbling or tripping
2.2
7.1
60
283
P16
ICPC
Acute alcohol abuse
2.7
7.1
37
140
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.5
7.1
200
1353
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.6
7.1
180
1190
A03FA02
ATC
cisapride; oral, rectal
1.8
7.1
110
640
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.0
7.0
71
358
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.9
7.0
86
464
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.2
7.0
56
258
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.9
7.0
81
429
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.2
7.0
57
265
WX720
NOMESCO Finland
Own respiration
1.9
7.0
86
465
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
3.3
7.0
25
76
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
7.0
194
1308
L29
ICPC
Musculoskeletal sympt/complt other
1.6
7.0
146
921
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.5
6.9
40
159
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
6.9
244
1727
R74
ICPC
Upper respiratory infection acute
1.3
6.9
525
4233
SPA47
NOMESCO Finland
Precision impression for denture
2.2
6.9
53
240
ZZH40
NOMESCO Finland
Substitute of bone
3.7
6.9
21
57
DFF00
NOMESCO Finland
Pure tone audiometry
1.6
6.9
167
1090
D12
ICPC
Constipation
2.1
6.9
62
300
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.2
6.9
53
241
R03BB01
ATC
ipratropium bromide; inhalant
2.2
6.8
54
248
U71
ICPC
Cystitis/urinary infection other
1.8
6.8
101
579
L15
ICPC
Knee symptom/complaint
1.4
6.8
410
3195
S03.1
ICD-10 Finland
Dislocation of septal cartilage of nose
40.2
6.8
8
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
16.8
6.7
10
6
N05BA12
ATC
alprazolam; oral
1.6
6.7
158
1024
B01AB05
ATC
enoxaparin; parenteral
1.3
6.7
478
3815
N04BC05
ATC
pramipexole; oral
1.7
6.7
121
733
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
6.7
310
2308
D07AC01
ATC
betamethasone; topical
1.3
6.7
579
4752
A02BA03
ATC
famotidine; systemic
2.2
6.7
56
263
L84
ICD-10 Finland
Corns and callosities
2.1
6.7
59
283
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.7
6.7
34
127
UDC00
NOMESCO Finland
Ear microscopy
1.7
6.7
117
704
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
2.4
6.7
45
193
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.1
6.7
62
304
K30
ICD-10 Finland
Functional dyspepsia
1.5
6.6
181
1215
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
6.6
154
996
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
6.6
193
1314
W10
ICD-10 Finland
Fall on and from stairs and steps
1.8
6.6
94
533
S04
ICPC
Lump/swelling localized
1.6
6.6
174
1160
N06AX12
ATC
bupropion; oral
1.7
6.6
114
684
TNG10
NOMESCO Finland
Puncture of knee
3.2
6.6
25
79
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
6.6
334
2529
R11
ICD-10 Finland
Nausea and vomiting
1.6
6.5
137
864
SPA02
NOMESCO Finland
Preparation for dental prosthetics
2.1
6.5
59
286
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
6.5
174
1162
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
2.8
6.5
31
112
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
6.5
427
3368
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
6.5
140
890
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
6.5
219
1539
N01
ICPC
Headache
1.5
6.4
172
1149
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.7
6.4
106
627
R07.3
ICD-10 Finland
Other chest pain
1.5
6.4
176
1182
4201
FHL
Tissue removal tissue, plastic
70.1
6.4
7
*
L84
ICPC
Back syndrome without radiat pain
1.8
6.4
85
471
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.9
6.4
72
378
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
6.4
213
1491
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
2.6
6.4
34
130
P15
ICPC
Chronic alcohol abuse
2.1
6.4
59
289
U07
ICPC
Urine symptom/complaint other
1.7
6.4
125
776
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.7
6.3
121
745
D19
ICPC
Teeth/gum symptom/complaint
1.3
6.3
505
4093
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
6.3
373
2890
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.3
6.3
46
204
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.7
6.3
104
615
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
3.2
6.3
24
76
H81.3
ICD-10 Finland
Other peripheral vertigo
2.3
6.3
47
211
DLD30
NOMESCO Finland
Construction of nose
+∞
6.3
6
*
M95.1
ICD-10 Finland
Cauliflower ear
+∞
6.3
6
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.9
6.2
79
432
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.1
6.2
57
278
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
6.2
157
1036
N05AA02
ATC
levomepromazine; systemic
2.0
6.2
65
333
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.6
6.2
35
138
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
5.0
6.2
18
36
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.2
412
3253
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.6
6.2
148
965
R06AX22
ATC
ebastine; oral
1.4
6.2
266
1956
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.7
6.2
109
658
L05
ICPC
Flank/axilla symptom/complaint
1.7
6.2
109
658
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
6.2
463
3720
G04BD08
ATC
solifenacin; oral
1.8
6.1
95
553
UJD02
NOMESCO Finland
Gastroscopy
1.9
6.1
73
392
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.4
6.1
41
176
DJW99
NOMESCO Finland
Other operation on septum of nose
12.6
6.1
10
8
SPE01
NOMESCO Finland
Mucosa-supported partial denture
2.4
6.1
40
170
L18
ICPC
Muscle pain
1.9
6.1
69
364
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
6.1
173
1173
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
6.1
92
532
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
6.1
125
786
C03CA01
ATC
furosemide; systemic
1.3
6.0
421
3345
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
2.2
6.0
47
215
R06AE09
ATC
levocetirizine; oral
1.5
6.0
221
1577
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
6.0
94
548
J01FA10
ATC
azithromycin; systemic
1.3
6.0
937
8266
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
6.0
154
1020

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Otolaryngology
4 [38004449]
1.4e+00
2.7e+00
3.5e+00
—
4.3e+00
3.4e+00
1.8e+00
cases:22.54%
controls:6.63%
cases:25.34%
controls:2.31%
cases:9.33%
controls:0.31%
—
—
cases:17.44%
controls:0.29%
cases:42.81%
controls:2.32%
cases:31.99%
controls:7.37%
314
906
1079
12749
353
316
1040
13339
130
42
1263
13613
—
243
39
1150
13605
589
313
787
13168
420
940
893
11812
Deviated nasal septum
J34.2 [45562448]
3.2e+00
4.6e+00
—
1.0e+50
1.0e+50
5.0e+00
2.7e+00
cases:6.17%
controls:0.28%
cases:10.48%
controls:0.12%
—
—
cases:8.83%
controls:0.00%
cases:5.46%
controls:0.00%
cases:11.48%
controls:0.09%
cases:5.03%
controls:0.35%
86
38
1307
13617
146
16
1247
13639
—
123
0
1270
13655
76
0
1317
13644
158
12
1218
13469
66
45
1247
12707
Plastic repair of septum of nose
DJD20 [2001301709]
2.4e+00
3.4e+00
1.0e+50
1.0e+50
1.0e+50
4.9e+00
3.1e+00
cases:1.79%
controls:0.17%
cases:1.08%
controls:0.04%
cases:0.50%
controls:0.00%
cases:4.09%
controls:0.00%
cases:2.15%
controls:0.00%
cases:5.81%
controls:0.04%
cases:2.82%
controls:0.13%
25
23
1368
13632
15
5
1378
13650
7
0
1386
13655
57
0
1336
13655
30
0
1363
13644
80
6
1296
13475
37
17
1276
12735
Other seropositive rheumatoid arthritis
M05.8 [45538634]
1.9e+00
2.1e+00
2.8e+00
—
2.6e+00
2.1e+00
1.8e+00
cases:2.73%
controls:0.40%
cases:2.66%
controls:0.34%
cases:1.36%
controls:0.08%
—
—
cases:1.22%
controls:0.10%
cases:2.40%
controls:0.30%
cases:2.67%
controls:0.43%
38
55
1355
13600
37
47
1356
13608
19
11
1374
13644
—
17
13
1376
13631
33
41
1343
13440
35
55
1278
12697
General anesthesia, balanced
WX408 [2001310808]
9.4e-01
1.5e+00
2.4e+00
1.0e+50
3.3e+00
3.0e+00
1.6e+00
cases:3.95%
controls:1.57%
cases:2.01%
controls:0.45%
cases:0.57%
controls:0.05%
cases:1.01%
controls:0.00%
cases:1.15%
controls:0.04%
cases:6.83%
controls:0.36%
cases:6.17%
controls:1.27%
55
215
1338
13440
28
62
1365
13593
8
7
1385
13648
14
0
1379
13655
16
6
1377
13638
94
48
1282
13433
81
162
1232
12590
More than one and less than three hours
ZXE10 [2001311401]
9.0e-01
1.3e+00
2.6e+00
—
3.8e+00
2.8e+00
1.3e+00
cases:6.25%
controls:2.63%
cases:2.51%
controls:0.73%
cases:0.57%
controls:0.04%
—
—
cases:2.01%
controls:0.04%
cases:8.14%
controls:0.53%
cases:8.53%
controls:2.39%
87
359
1306
13296
35
100
1358
13555
8
6
1385
13649
—
28
6
1365
13638
112
71
1264
13410
112
305
1201
12447
Scheduled procedure
ZXD10 [2001311387]
9.3e-01
1.2e+00
2.7e+00
1.0e+50
3.1e+00
2.9e+00
1.6e+00
cases:7.39%
controls:3.05%
cases:3.23%
controls:0.98%
cases:1.44%
controls:0.10%
cases:3.95%
controls:0.00%
cases:2.01%
controls:0.10%
cases:9.45%
controls:0.58%
cases:11.42%
controls:2.63%
103
417
1290
13238
45
134
1348
13521
20
13
1373
13642
55
0
1338
13655
28
13
1365
13631
130
78
1246
13403
150
335
1163
12417
Outpatient Visit
OP [9202]
5.4e-01
8.9e-01
1.1e+00
5.8e+00
1.6e+00
1.3e+00
8.4e-01
cases:58.08%
controls:44.69%
cases:47.45%
controls:27.13%
cases:16.37%
controls:6.06%
cases:56.28%
controls:0.37%
cases:23.47%
controls:5.95%
cases:59.38%
controls:27.69%
cases:72.51%
controls:53.18%
809
6103
584
7552
661
3705
732
9950
228
827
1165
12828
784
51
609
13604
327
812
1066
12832
817
3733
559
9748
952
6781
361
5971
Fracture of nasal bones, closed
S02.20 [45755755]
3.9e+00
—
1.0e+50
1.0e+50
—
3.8e+00
3.0e+00
cases:3.16%
controls:0.07%
—
—
cases:1.29%
controls:0.00%
cases:0.72%
controls:0.00%
—
—
cases:1.67%
controls:0.04%
cases:1.22%
controls:0.06%
44
9
1349
13646
—
18
0
1375
13655
10
0
1383
13655
—
23
5
1353
13476
16
8
1297
12744
Rhinopharyngoscopy
UDH02 [2001301680]
1.9e+00
3.3e+00
—
1.0e+50
—
3.4e+00
1.9e+00
cases:1.65%
controls:0.24%
cases:1.36%
controls:0.05%
—
—
cases:1.22%
controls:0.00%
—
—
cases:1.31%
controls:0.04%
cases:1.83%
controls:0.27%
23
33
1370
13622
19
7
1374
13648
—
17
0
1376
13655
—
18
6
1358
13475
24
34
1289
12718
leflunomide; oral
L04AK01 [955035]
2.3e+00
3.0e+00
—
—
—
3.0e+00
2.1e+00
cases:0.79%
controls:0.08%
cases:0.72%
controls:0.04%
—
—
—
—
—
—
cases:0.87%
controls:0.04%
cases:0.91%
controls:0.11%
11
11
1382
13644
10
5
1383
13650
—
—
—
12
6
1364
13475
12
14
1301
12738
Chronic maxillary sinusitis
J32.0 [45586667]
1.6e+00
2.0e+00
2.8e+00
1.0e+50
—
2.2e+00
1.2e+00
cases:2.08%
controls:0.42%
cases:1.22%
controls:0.16%
cases:0.57%
controls:0.04%
cases:1.01%
controls:0.00%
—
—
cases:1.45%
controls:0.16%
cases:1.68%
controls:0.51%
29
58
1364
13597
17
22
1376
13633
8
5
1385
13650
14
0
1379
13655
—
20
21
1356
13460
22
65
1291
12687
One hour or less
ZXE00 [2001311394]
8.7e-01
1.2e+00
2.0e+00
—
2.2e+00
2.0e+00
1.4e+00
cases:7.32%
controls:3.21%
cases:2.80%
controls:0.88%
cases:0.79%
controls:0.10%
—
—
cases:0.50%
controls:0.06%
cases:5.38%
controls:0.73%
cases:10.36%
controls:2.77%
102
439
1291
13216
39
120
1354
13535
11
14
1382
13641
—
7
8
1386
13636
74
98
1302
13383
136
353
1177
12399
Turbinoplasty
DHB50 [2001301693]
2.2e+00
—
—
1.0e+50
1.0e+50
3.8e+00
2.9e+00
cases:1.29%
controls:0.14%
—
—
—
—
cases:0.36%
controls:0.00%
cases:0.36%
controls:0.00%
cases:1.89%
controls:0.04%
cases:2.28%
controls:0.13%
18
19
1375
13636
—
—
5
0
1388
13655
5
0
1388
13644
26
6
1350
13475
30
16
1283
12736
Rheumatology
66 [38004491]
1.2e+00
1.5e+00
1.6e+00
—
1.6e+00
1.6e+00
1.3e+00
cases:4.74%
controls:1.46%
cases:3.73%
controls:0.85%
cases:0.93%
controls:0.18%
—
—
cases:0.72%
controls:0.15%
cases:3.78%
controls:0.82%
cases:6.02%
controls:1.80%
66
199
1327
13456
52
116
1341
13539
13
25
1380
13630
—
10
20
1383
13624
52
110
1324
13371
79
229
1234
12523
Surface analgesia on skin or mucosa
WX105 [2001310765]
1.3e+00
2.1e+00
—
—
—
3.6e+00
1.5e+00
cases:1.79%
controls:0.49%
cases:1.01%
controls:0.12%
—
—
—
—
—
—
cases:4.07%
controls:0.11%
cases:2.44%
controls:0.56%
25
67
1368
13588
14
17
1379
13638
—
—
—
56
15
1320
13466
32
71
1281
12681
Chronic rhinitis
J31.0 [45572165]
1.5e+00
2.9e+00
—
1.0e+50
—
2.3e+00
1.8e+00
cases:1.72%
controls:0.40%
cases:2.08%
controls:0.12%
—
—
cases:1.15%
controls:0.00%
—
—
cases:1.31%
controls:0.13%
cases:2.74%
controls:0.49%
24
54
1369
13601
29
16
1364
13639
—
16
0
1377
13655
—
18
18
1358
13463
36
62
1277
12690
Mouth breathing
R06.5 [45573006]
1.2e+00
2.8e+00
1.0e+50
1.0e+50
—
2.9e+00
1.3e+00
cases:1.94%
controls:0.60%
cases:1.72%
controls:0.10%
cases:0.65%
controls:0.00%
cases:1.08%
controls:0.00%
—
—
cases:1.82%
controls:0.10%
cases:2.13%
controls:0.57%
27
82
1366
13573
24
14
1369
13641
9
0
1384
13655
15
0
1378
13655
—
25
14
1351
13467
28
73
1285
12679
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.1e+00
1.3e+00
1.5e+00
—
1.5e+00
1.3e+00
1.2e+00
cases:4.74%
controls:1.70%
cases:3.02%
controls:0.81%
cases:1.15%
controls:0.26%
—
—
cases:1.22%
controls:0.28%
cases:3.27%
controls:0.88%
cases:5.79%
controls:1.78%
66
232
1327
13423
42
111
1351
13544
16
36
1377
13619
—
17
38
1376
13606
45
118
1331
13363
76
227
1237
12525
prednisone; oral
H02AB07 [21602735]
1.2e+00
1.5e+00
2.6e+00
—
1.8e+00
1.3e+00
1.1e+00
cases:3.02%
controls:0.89%
cases:1.01%
controls:0.23%
cases:0.50%
controls:0.04%
—
—
cases:0.36%
controls:0.06%
cases:1.38%
controls:0.36%
cases:3.35%
controls:1.11%
42
122
1351
13533
14
32
1379
13623
7
5
1386
13650
—
5
8
1388
13636
19
49
1357
13432
44
142
1269
12610
prednisone
A07EA03 [21600655]
1.2e+00
1.5e+00
2.6e+00
—
1.8e+00
1.3e+00
1.1e+00
cases:3.02%
controls:0.89%
cases:1.01%
controls:0.23%
cases:0.50%
controls:0.04%
—
—
cases:0.36%
controls:0.06%
cases:1.38%
controls:0.36%
cases:3.35%
controls:1.11%
42
122
1351
13533
14
32
1379
13623
7
5
1386
13650
—
5
8
1388
13636
19
49
1357
13432
44
142
1269
12610
Outpatient Hospital
22 [8756]
5.9e-01
9.3e-01
1.1e+00
—
2.3e+00
1.9e+00
8.7e-01
cases:24.26%
controls:15.14%
cases:10.41%
controls:4.39%
cases:1.79%
controls:0.61%
—
—
cases:5.53%
controls:0.56%
cases:22.67%
controls:4.27%
cases:30.39%
controls:15.49%
338
2068
1055
11587
145
600
1248
13055
25
83
1368
13572
—
77
76
1316
13568
312
575
1064
12906
399
1975
914
10777
Wegener granulomatosis
M31.3 [45591818]
2.8e+00
2.3e+00
—
—
—
2.6e+00
—
cases:0.57%
controls:0.04%
cases:0.43%
controls:0.04%
—
—
—
—
—
—
cases:0.58%
controls:0.04%
—
—
8
5
1385
13650
6
6
1387
13649
—
—
—
8
6
1368
13475
—
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
8.8e-01
1.1e+00
1.8e+00
—
1.6e+00
1.1e+00
9.7e-01
cases:9.48%
controls:4.17%
cases:4.02%
controls:1.32%
cases:1.15%
controls:0.20%
—
—
cases:1.15%
controls:0.23%
cases:4.29%
controls:1.46%
cases:11.42%
controls:4.66%
132
569
1261
13086
56
180
1337
13475
16
27
1377
13628
—
16
31
1377
13613
59
197
1317
13284
150
594
1163
12158
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
1.7e+00
2.2e+00
—
—
—
2.0e+00
1.6e+00
cases:1.44%
controls:0.28%
cases:1.15%
controls:0.12%
—
—
—
—
—
—
cases:0.94%
controls:0.13%
cases:1.60%
controls:0.31%
20
38
1373
13617
16
17
1377
13638
—
—
—
13
18
1363
13463
21
40
1292
12712
Sleep apnoea
G47.3 [45562094]
6.2e-01
1.3e+00
1.4e+00
—
1.7e+00
1.4e+00
1.0e+00
cases:3.59%
controls:1.96%
cases:4.67%
controls:1.34%
cases:1.08%
controls:0.27%
—
—
cases:1.36%
controls:0.26%
cases:5.52%
controls:1.41%
cases:7.77%
controls:2.98%
50
268
1343
13387
65
183
1328
13472
15
37
1378
13618
—
19
35
1374
13609
76
190
1300
13291
102
380
1211
12372
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
5.3e-01
1.0e+00
1.1e+00
3.0e+00
1.1e+00
9.2e-01
8.4e-01
cases:6.53%
controls:3.95%
cases:4.52%
controls:1.67%
cases:1.08%
controls:0.37%
cases:0.72%
controls:0.04%
cases:0.86%
controls:0.29%
cases:3.63%
controls:1.48%
cases:9.82%
controls:4.49%
91
540
1302
13115
63
228
1330
13427
15
50
1378
13605
10
5
1383
13650
12
40
1381
13604
50
200
1326
13281
129
572
1184
12180
mupirocin; nasal
R01AX06 [21603201]
1.3e+00
1.9e+00
—
—
—
3.7e+00
1.7e+00
cases:0.72%
controls:0.19%
cases:0.57%
controls:0.09%
—
—
—
—
—
—
cases:1.53%
controls:0.04%
cases:1.37%
controls:0.25%
10
26
1383
13629
8
12
1385
13643
—
—
—
21
5
1355
13476
18
32
1295
12720
mometasone; nasal
R01AD09 [21605051]
9.6e-01
1.5e+00
1.4e+00
—
1.6e+00
1.2e+00
6.6e-01
cases:12.49%
controls:5.16%
cases:8.33%
controls:2.03%
cases:1.08%
controls:0.27%
—
—
cases:1.36%
controls:0.27%
cases:6.69%
controls:2.12%
cases:11.96%
controls:6.53%
174
705
1219
12950
116
277
1277
13378
15
37
1378
13618
—
19
37
1374
13607
92
286
1284
13195
157
833
1156
11919
fluticasone; nasal
R01AD08 [21605050]
8.6e-01
1.3e+00
1.2e+00
—
2.0e+00
1.1e+00
7.7e-01
cases:12.06%
controls:5.49%
cases:7.82%
controls:2.26%
cases:1.15%
controls:0.34%
—
—
cases:2.23%
controls:0.30%
cases:6.54%
controls:2.23%
cases:12.03%
controls:5.95%
168
750
1225
12905
109
309
1284
13346
16
46
1377
13609
—
31
41
1362
13603
90
300
1286
13181
158
759
1155
11993
fluticasone furoate; nasal
R01AD12 [21605053]
8.6e-01
1.3e+00
1.2e+00
—
2.0e+00
1.1e+00
7.7e-01
cases:12.06%
controls:5.49%
cases:7.82%
controls:2.26%
cases:1.15%
controls:0.34%
—
—
cases:2.23%
controls:0.30%
cases:6.54%
controls:2.23%
cases:12.03%
controls:5.95%
168
750
1225
12905
109
309
1284
13346
16
46
1377
13609
—
31
41
1362
13603
90
300
1286
13181
158
759
1155
11993
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.1e+00
1.9e+00
—
—
—
2.1e+00
2.2e+00
cases:1.58%
controls:0.52%
cases:1.08%
controls:0.17%
—
—
—
—
—
—
cases:0.87%
controls:0.11%
cases:2.36%
controls:0.27%
22
71
1371
13584
15
23
1378
13632
—
—
—
12
15
1364
13466
31
34
1282
12718
FEV1 --post bronchodilation
20155-8 [3023550]
1.1e+00
1.9e+00
—
—
—
2.1e+00
2.2e+00
cases:1.58%
controls:0.52%
cases:1.08%
controls:0.17%
—
—
—
—
—
—
cases:0.87%
controls:0.11%
cases:2.36%
controls:0.27%
22
71
1371
13584
15
23
1378
13632
—
—
—
12
15
1364
13466
31
34
1282
12718
FVC percent change Respiratory system
69982-7 [42868471]
1.1e+00
1.9e+00
—
—
—
2.1e+00
2.2e+00
cases:1.58%
controls:0.52%
cases:1.08%
controls:0.17%
—
—
—
—
—
—
cases:0.87%
controls:0.11%
cases:2.36%
controls:0.27%
22
71
1371
13584
15
23
1378
13632
—
—
—
12
15
1364
13466
31
34
1282
12718
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.1e+00
1.9e+00
—
—
—
2.1e+00
2.2e+00
cases:1.58%
controls:0.52%
cases:1.08%
controls:0.17%
—
—
—
—
—
—
cases:0.87%
controls:0.11%
cases:2.36%
controls:0.27%
22
71
1371
13584
15
23
1378
13632
—
—
—
12
15
1364
13466
31
34
1282
12718
FEV1 percent change
69983-5 [42868472]
1.1e+00
1.9e+00
—
—
—
2.1e+00
2.2e+00
cases:1.58%
controls:0.52%
cases:1.08%
controls:0.17%
—
—
—
—
—
—
cases:0.87%
controls:0.11%
cases:2.36%
controls:0.27%
22
71
1371
13584
15
23
1378
13632
—
—
—
12
15
1364
13466
31
34
1282
12718
ibuprofen
R02AX02 [1588667]
3.6e-01
6.0e-01
7.4e-01
3.0e+00
9.9e-01
8.6e-01
5.5e-01
cases:30.15%
controls:23.18%
cases:17.95%
controls:10.70%
cases:3.02%
controls:1.46%
cases:1.22%
controls:0.06%
cases:4.24%
controls:1.61%
cases:22.67%
controls:11.02%
cases:39.38%
controls:27.25%
420
3165
973
10490
250
1461
1143
12194
42
199
1351
13456
17
8
1376
13647
59
220
1334
13424
312
1486
1064
11995
517
3475
796
9277
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
3.6e-01
6.0e-01
7.4e-01
3.0e+00
9.9e-01
8.6e-01
5.5e-01
cases:30.15%
controls:23.18%
cases:17.95%
controls:10.70%
cases:3.02%
controls:1.46%
cases:1.22%
controls:0.06%
cases:4.24%
controls:1.61%
cases:22.67%
controls:11.02%
cases:39.38%
controls:27.25%
420
3165
973
10490
250
1461
1143
12194
42
199
1351
13456
17
8
1376
13647
59
220
1334
13424
312
1486
1064
11995
517
3475
796
9277
FEV1/FVC
19926-5 [3011505]
1.0e+00
1.9e+00
—
—
—
2.0e+00
2.1e+00
cases:1.65%
controls:0.59%
cases:1.22%
controls:0.18%
—
—
—
—
—
—
cases:0.94%
controls:0.13%
cases:2.36%
controls:0.30%
23
80
1370
13575
17
24
1376
13631
—
—
—
13
17
1363
13464
31
38
1282
12714
FEV1
20150-9 [3024653]
1.0e+00
1.9e+00
—
—
—
2.0e+00
2.1e+00
cases:1.65%
controls:0.59%
cases:1.22%
controls:0.18%
—
—
—
—
—
—
cases:0.94%
controls:0.13%
cases:2.36%
controls:0.30%
23
80
1370
13575
17
24
1376
13631
—
—
—
13
17
1363
13464
31
38
1282
12714
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.0e+00
1.9e+00
—
—
—
2.0e+00
2.1e+00
cases:1.65%
controls:0.59%
cases:1.22%
controls:0.18%
—
—
—
—
—
—
cases:0.94%
controls:0.13%
cases:2.36%
controls:0.30%
23
80
1370
13575
17
24
1376
13631
—
—
—
13
17
1363
13464
31
38
1282
12714
Infiltration anesthesia
WX110 [2001310767]
5.4e-01
5.0e-01
4.8e-01
3.3e+00
1.0e+00
1.2e+00
4.9e-01
cases:12.99%
controls:8.04%
cases:5.89%
controls:3.64%
cases:0.79%
controls:0.49%
cases:1.22%
controls:0.04%
cases:1.22%
controls:0.44%
cases:9.88%
controls:3.32%
cases:17.75%
controls:11.72%
181
1098
1212
12557
82
497
1311
13158
11
67
1382
13588
17
6
1376
13649
17
60
1376
13584
136
447
1240
13034
233
1495
1080
11257
Pulmonary Disease
29 [38004472]
5.9e-01
1.1e+00
1.3e+00
—
1.7e+00
1.2e+00
8.8e-01
cases:7.47%
controls:4.26%
cases:6.53%
controls:2.25%
cases:1.29%
controls:0.36%
—
—
cases:1.72%
controls:0.31%
cases:7.05%
controls:2.26%
cases:12.19%
controls:5.42%
104
582
1289
13073
91
307
1302
13348
18
49
1375
13606
—
24
42
1369
13602
97
305
1279
13176
160
691
1153
12061
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
4.5e-01
6.2e-01
7.8e-01
2.2e+00
1.2e+00
8.0e-01
5.6e-01
cases:20.53%
controls:14.09%
cases:12.63%
controls:7.22%
cases:2.30%
controls:1.06%
cases:0.50%
controls:0.06%
cases:3.30%
controls:1.01%
cases:15.48%
controls:7.57%
cases:30.54%
controls:20.03%
286
1924
1107
11731
176
986
1217
12669
32
145
1361
13510
7
8
1386
13647
46
138
1347
13506
213
1021
1163
12460
401
2554
912
10198
Inpatient Hospital
21 [8717]
5.3e-01
7.5e-01
8.5e-01
—
2.1e+00
1.5e+00
7.5e-01
cases:32.16%
controls:21.85%
cases:13.28%
controls:6.77%
cases:2.23%
controls:0.96%
—
—
cases:6.32%
controls:0.78%
cases:24.78%
controls:6.61%
cases:36.25%
controls:21.15%
448
2983
945
10672
185
924
1208
12731
31
131
1362
13524
—
88
107
1305
13537
341
891
1035
12590
476
2697
837
10055
codeine and paracetamol
N02AJ06 [1123647]
5.1e-01
1.0e+00
1.3e+00
—
1.8e+00
1.2e+00
7.2e-01
cases:9.98%
controls:6.27%
cases:6.46%
controls:2.42%
cases:1.51%
controls:0.40%
—
—
cases:1.72%
controls:0.30%
cases:8.14%
controls:2.60%
cases:15.84%
controls:8.41%
139
856
1254
12799
90
331
1303
13324
21
54
1372
13601
—
24
41
1369
13603
112
350
1264
13131
208
1073
1105
11679
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
1.2e+00
2.0e+00
—
—
—
2.0e+00
1.2e+00
cases:1.22%
controls:0.36%
cases:0.57%
controls:0.08%
—
—
—
—
—
—
cases:1.16%
controls:0.16%
cases:1.37%
controls:0.42%
17
49
1376
13606
8
11
1385
13644
—
—
—
16
21
1360
13460
18
53
1295
12699
Physiotherapist
Z3226 [2001311560]
5.5e-01
1.6e+00
—
—
2.1e+00
1.6e+00
1.0e+00
cases:2.30%
controls:1.33%
cases:1.44%
controls:0.31%
—
—
—
—
cases:0.57%
controls:0.07%
cases:1.67%
controls:0.34%
cases:2.89%
controls:1.04%
32
182
1361
13473
20
42
1373
13613
—
—
8
10
1385
13634
23
46
1353
13435
38
132
1275
12620
More than three and less than five hours
ZXE20 [2001311408]
1.1e+00
1.4e+00
—
—
—
2.5e+00
1.1e+00
cases:1.51%
controls:0.52%
cases:0.79%
controls:0.21%
—
—
—
—
—
—
cases:1.96%
controls:0.16%
cases:1.83%
controls:0.60%
21
71
1372
13584
11
28
1382
13627
—
—
—
27
22
1349
13459
24
76
1289
12676
Foot and toes X-ray examination
NH3AA [2001308267]
7.7e-01
2.1e+00
—
—
—
2.2e+00
1.7e+00
cases:1.01%
controls:0.47%
cases:0.79%
controls:0.10%
—
—
—
—
—
—
cases:0.80%
controls:0.09%
cases:2.28%
controls:0.45%
14
64
1379
13591
11
13
1382
13642
—
—
—
11
12
1365
13469
30
57
1283
12695
Physiotherapy
R4110 [2001310233]
7.0e-01
1.3e+00
—
—
1.8e+00
1.2e+00
9.2e-01
cases:3.66%
controls:1.85%
cases:1.94%
controls:0.56%
—
—
—
—
cases:0.50%
controls:0.08%
cases:1.82%
controls:0.53%
cases:4.34%
controls:1.77%
51
252
1342
13403
27
76
1366
13579
—
—
7
11
1386
13633
25
72
1351
13409
57
226
1256
12526
cefalexin; oral
J01DB01 [21602870]
4.6e-01
8.5e-01
9.0e-01
—
2.1e+00
1.2e+00
4.7e-01
cases:28.36%
controls:20.01%
cases:13.71%
controls:6.38%
cases:1.72%
controls:0.71%
—
—
cases:5.46%
controls:0.73%
cases:19.26%
controls:6.71%
cases:32.06%
controls:22.74%
395
2732
998
10923
191
871
1202
12784
24
97
1369
13558
—
76
100
1317
13544
265
904
1111
12577
421
2900
892
9852
pregabalin; oral
N02BF02 [955152]
1.1e+00
1.1e+00
9.0e-01
—
1.4e+00
1.2e+00
1.1e+00
cases:3.80%
controls:1.36%
cases:2.37%
controls:0.77%
cases:0.72%
controls:0.29%
—
—
cases:1.08%
controls:0.27%
cases:2.47%
controls:0.74%
cases:5.86%
controls:2.03%
53
186
1340
13469
33
105
1360
13550
10
40
1383
13615
—
15
37
1378
13607
34
100
1342
13381
77
259
1236
12493
General Surgery
2 [38004447]
6.6e-01
8.0e-01
1.3e+00
—
1.5e+00
9.3e-01
6.7e-01
cases:27.35%
controls:16.24%
cases:10.55%
controls:5.02%
cases:2.08%
controls:0.59%
—
—
cases:2.66%
controls:0.59%
cases:11.56%
controls:4.89%
cases:26.66%
controls:15.66%
381
2217
1012
11438
147
686
1246
12969
29
81
1364
13574
—
37
80
1356
13564
159
659
1217
12822
350
1997
963
10755
Remowal of suture of skin
TQW40 [2001310146]
9.7e-01
2.3e+00
—
—
—
2.1e+00
1.4e+00
cases:0.79%
controls:0.30%
cases:0.43%
controls:0.04%
—
—
—
—
—
—
cases:0.58%
controls:0.07%
cases:0.99%
controls:0.24%
11
41
1382
13614
6
6
1387
13649
—
—
—
8
10
1368
13471
13
30
1300
12722
Left side
ZXA05 [2001311347]
1.0e+00
8.6e-01
2.5e+00
—
—
1.4e+00
8.9e-01
cases:3.59%
controls:1.32%
cases:0.93%
controls:0.40%
cases:0.43%
controls:0.04%
—
—
—
—
cases:1.53%
controls:0.38%
cases:3.66%
controls:1.54%
50
180
1343
13475
13
54
1380
13601
6
5
1387
13650
—
—
21
51
1355
13430
48
196
1265
12556
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
4.6e-01
9.2e-01
7.6e-01
—
2.8e+00
1.1e+00
4.0e-01
cases:7.39%
controls:4.80%
cases:3.66%
controls:1.49%
cases:0.36%
controls:0.17%
—
—
cases:2.66%
controls:0.16%
cases:3.78%
controls:1.28%
cases:6.93%
controls:4.77%
103
655
1290
13000
51
204
1342
13451
5
23
1388
13632
—
37
22
1356
13622
52
172
1324
13309
91
608
1222
12144
Physical Medicine And Rehabilitation
25 [38004468]
9.8e-01
1.1e+00
1.1e+00
1.0e+50
1.4e+00
1.2e+00
9.4e-01
cases:8.18%
controls:3.25%
cases:3.45%
controls:1.16%
cases:0.79%
controls:0.26%
cases:1.65%
controls:0.00%
cases:0.79%
controls:0.20%
cases:3.92%
controls:1.17%
cases:10.21%
controls:4.24%
114
444
1279
13211
48
158
1345
13497
11
35
1382
13620
23
0
1370
13655
11
27
1382
13617
54
158
1322
13323
134
541
1179
12211
Cone beam CT of paranasal sinus
DM1AI [2001301744]
—
2.8e+00
—
1.0e+50
—
2.9e+00
1.3e+00
—
—
cases:0.57%
controls:0.04%
—
—
cases:0.93%
controls:0.00%
—
—
cases:0.65%
controls:0.04%
cases:0.53%
controls:0.14%
—
8
5
1385
13650
—
13
0
1380
13655
—
9
5
1367
13476
7
18
1306
12734
temazepam; oral
N05CD07 [21604642]
9.2e-01
1.0e+00
1.3e+00
—
1.6e+00
1.0e+00
1.1e+00
cases:3.95%
controls:1.61%
cases:2.51%
controls:0.92%
cases:0.65%
controls:0.18%
—
—
cases:1.08%
controls:0.23%
cases:2.76%
controls:0.99%
cases:5.48%
controls:1.97%
55
220
1338
13435
35
125
1358
13530
9
25
1384
13630
—
15
31
1378
13613
38
133
1338
13348
72
251
1241
12501
Orthopedic Surgery
20 [38004465]
6.4e-01
8.1e-01
1.1e+00
—
1.2e+00
1.1e+00
7.9e-01
cases:12.92%
controls:7.26%
cases:6.32%
controls:2.90%
cases:1.44%
controls:0.48%
—
—
cases:1.44%
controls:0.44%
cases:7.92%
controls:2.89%
cases:17.75%
controls:8.93%
180
991
1213
12664
88
396
1305
13259
20
65
1373
13590
—
20
60
1373
13584
109
390
1267
13091
233
1139
1080
11613
Other specified disorders of nose and nasal sinuses
J34.8 [45576947]
2.4e+00
—
—
1.0e+50
—
—
3.2e+00
cases:0.50%
controls:0.04%
—
—
—
—
cases:0.43%
controls:0.00%
—
—
—
—
cases:0.91%
controls:0.04%
7
6
1386
13649
—
—
6
0
1387
13655
—
—
12
5
1301
12747
Day surgery
ZXD20 [2001311388]
1.2e+00
1.4e+00
—
1.0e+50
—
1.7e+00
1.2e+00
cases:2.08%
controls:0.61%
cases:0.79%
controls:0.19%
—
—
cases:0.57%
controls:0.00%
—
—
cases:1.09%
controls:0.21%
cases:2.44%
controls:0.77%
29
83
1364
13572
11
26
1382
13629
—
8
0
1385
13655
—
15
28
1361
13453
32
98
1281
12654
Rheumatoid/seropositive arthritis
L88 [2002000707]
1.0e+00
1.7e+00
—
—
—
1.8e+00
1.8e+00
cases:0.57%
controls:0.21%
cases:0.57%
controls:0.10%
—
—
—
—
—
—
cases:0.58%
controls:0.10%
cases:1.07%
controls:0.18%
8
28
1385
13627
8
14
1385
13641
—
—
—
8
13
1368
13468
14
23
1299
12729
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.5e+00
1.4e+00
1.2e+00
—
—
1.2e+00
1.1e+00
cases:1.87%
controls:0.42%
cases:1.01%
controls:0.26%
cases:0.36%
controls:0.11%
—
—
—
—
cases:0.94%
controls:0.27%
cases:2.21%
controls:0.72%
26
58
1367
13597
14
35
1379
13620
5
15
1388
13640
—
—
13
37
1363
13444
29
92
1284
12660
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
1.2e+00
—
—
—
—
2.2e+00
1.9e+00
cases:0.86%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.51%
controls:0.06%
cases:1.45%
controls:0.23%
12
35
1381
13620
—
—
—
—
7
8
1369
13473
19
29
1294
12723
Chronic pansinusitis
J32.4 [45581854]
—
—
—
1.0e+50
—
2.6e+00
2.6e+00
—
—
—
—
—
—
cases:0.36%
controls:0.00%
—
—
cases:0.58%
controls:0.04%
cases:0.53%
controls:0.04%
—
—
—
5
0
1388
13655
—
8
6
1368
13475
7
5
1306
12747
Seropositive rheumatoid arthritis
M05 [45606038]
2.7e+00
—
—
—
—
—
2.4e+00
cases:1.01%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.05%
14
9
1379
13646
—
—
—
—
—
7
6
1306
12746
Inpatient Visit
IP [9201]
4.9e-01
8.4e-01
3.2e-01
—
1.6e+00
1.3e+00
8.8e-01
cases:16.30%
controls:10.70%
cases:6.60%
controls:2.97%
cases:0.50%
controls:0.37%
—
—
cases:1.58%
controls:0.31%
cases:8.94%
controls:2.69%
cases:15.31%
controls:6.97%
227
1461
1166
12194
92
405
1301
13250
7
50
1386
13605
—
22
42
1371
13602
123
363
1253
13118
201
889
1112
11863
oxazepam; oral
N05BA04 [21604569]
1.1e+00
8.8e-01
1.4e+00
—
9.2e-01
9.1e-01
8.4e-01
cases:6.60%
controls:2.39%
cases:3.37%
controls:1.43%
cases:1.08%
controls:0.28%
—
—
cases:1.01%
controls:0.40%
cases:3.49%
controls:1.44%
cases:7.01%
controls:3.14%
92
327
1301
13328
47
195
1346
13460
15
38
1378
13617
—
14
55
1379
13589
48
194
1328
13287
92
401
1221
12351
Nose symptom/complaint other
R08 [2002000889]
2.2e+00
—
—
—
—
2.8e+00
1.7e+00
cases:0.93%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.04%
cases:0.53%
controls:0.10%
13
14
1380
13641
—
—
—
—
8
5
1368
13476
7
13
1306
12739
zopiclone; oral
N05CF01 [21604654]
6.6e-01
8.1e-01
1.0e+00
—
9.0e-01
8.8e-01
7.1e-01
cases:6.75%
controls:3.61%
cases:4.31%
controls:1.96%
cases:1.15%
controls:0.42%
—
—
cases:1.29%
controls:0.53%
cases:5.01%
controls:2.14%
cases:8.99%
controls:4.61%
94
493
1299
13162
60
268
1333
13387
16
58
1377
13597
—
18
72
1375
13572
69
288
1307
13193
118
588
1195
12164
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
7.4e-01
8.9e-01
1.8e+00
—
1.1e+00
8.2e-01
6.7e-01
cases:9.05%
controls:4.55%
cases:3.59%
controls:1.51%
cases:0.65%
controls:0.10%
—
—
cases:0.36%
controls:0.12%
cases:3.56%
controls:1.60%
cases:11.12%
controls:6.04%
126
621
1267
13034
50
206
1343
13449
9
14
1384
13641
—
5
16
1388
13628
49
216
1327
13265
146
770
1167
11982
Low back pain
M54.5 [45553207]
7.7e-01
7.7e-01
1.7e+00
—
1.2e+00
9.3e-01
7.9e-01
cases:4.74%
controls:2.25%
cases:1.79%
controls:0.84%
cases:0.57%
controls:0.11%
—
—
cases:0.36%
controls:0.11%
cases:2.11%
controls:0.85%
cases:6.85%
controls:3.24%
66
307
1327
13348
25
115
1368
13540
8
15
1385
13640
—
5
15
1388
13629
29
114
1347
13367
90
413
1223
12339
Application of heat
ZXC60 [2001311371]
2.4e+00
1.0e+50
—
—
—
—
2.4e+00
cases:0.72%
controls:0.07%
cases:0.36%
controls:0.00%
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.09%
10
9
1383
13646
5
0
1388
13655
—
—
—
—
13
11
1300
12741
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
1.5e+00
1.5e+00
—
—
—
2.3e+00
1.1e+00
cases:1.36%
controls:0.32%
cases:0.50%
controls:0.11%
—
—
—
—
—
—
cases:0.94%
controls:0.10%
cases:0.99%
controls:0.34%
19
44
1374
13611
7
15
1386
13640
—
—
—
13
13
1363
13468
13
43
1300
12709
Car occupant [any] injured in unspecified traffic accident
V49.9 [45566025]
8.0e-01
2.1e+00
—
—
—
2.7e+00
1.3e+00
cases:0.50%
controls:0.23%
cases:0.43%
controls:0.05%
—
—
—
—
—
—
cases:0.65%
controls:0.04%
cases:0.61%
controls:0.16%
7
31
1386
13624
6
7
1387
13648
—
—
—
9
6
1367
13475
8
21
1305
12731
Hypertrophy of nasal turbinates
J34.3 [45543264]
2.6e+00
—
—
1.0e+50
—
—
2.2e+00
cases:1.08%
controls:0.08%
—
—
—
—
cases:1.08%
controls:0.00%
—
—
—
—
cases:1.14%
controls:0.13%
15
11
1378
13644
—
—
15
0
1378
13655
—
—
15
16
1298
12736
rituximab
L01FA01 [955167]
2.3e+00
—
—
—
—
—
2.5e+00
cases:0.50%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.05%
7
7
1386
13648
—
—
—
—
—
9
7
1304
12745
methotrexate; oral, parenteral
L04AX03 [21603929]
1.2e+00
1.2e+00
1.1e+00
—
1.2e+00
1.2e+00
1.1e+00
cases:2.94%
controls:0.89%
cases:2.23%
controls:0.67%
cases:0.65%
controls:0.22%
—
—
cases:0.72%
controls:0.23%
cases:2.40%
controls:0.71%
cases:3.05%
controls:1.06%
41
121
1352
13534
31
91
1362
13564
9
30
1384
13625
—
10
31
1383
13613
33
96
1343
13385
40
135
1273
12617
methotrexate
L01BA01 [21601423]
1.2e+00
1.2e+00
1.1e+00
—
1.2e+00
1.2e+00
1.1e+00
cases:2.94%
controls:0.89%
cases:2.23%
controls:0.67%
cases:0.65%
controls:0.22%
—
—
cases:0.72%
controls:0.23%
cases:2.40%
controls:0.71%
cases:3.05%
controls:1.06%
41
121
1352
13534
31
91
1362
13564
9
30
1384
13625
—
10
31
1383
13613
33
96
1343
13385
40
135
1273
12617
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
5.2e-01
5.1e-01
1.1e+00
—
1.2e+00
6.1e-01
7.9e-01
cases:15.87%
controls:10.05%
cases:5.74%
controls:3.52%
cases:1.36%
controls:0.44%
—
—
cases:1.22%
controls:0.38%
cases:6.40%
controls:3.59%
cases:23.23%
controls:12.09%
221
1373
1172
12282
80
480
1313
13175
19
60
1374
13595
—
17
52
1376
13592
88
484
1288
12997
305
1542
1008
11210
escitalopram; oral
N06AB10 [21604718]
7.2e-01
8.3e-01
9.2e-01
—
1.3e+00
1.0e+00
8.8e-01
cases:4.31%
controls:2.15%
cases:2.87%
controls:1.27%
cases:0.79%
controls:0.31%
—
—
cases:0.93%
controls:0.26%
cases:3.27%
controls:1.18%
cases:5.86%
controls:2.52%
60
294
1333
13361
40
174
1353
13481
11
43
1382
13612
—
13
36
1380
13608
45
159
1331
13322
77
321
1236
12431
Emergency Room Visit
ER [9203]
5.4e-01
8.0e-01
1.1e+00
—
9.5e-01
7.6e-01
5.6e-01
cases:30.08%
controls:19.97%
cases:14.43%
controls:7.05%
cases:2.44%
controls:0.84%
—
—
cases:2.44%
controls:0.96%
cases:14.24%
controls:7.22%
cases:32.29%
controls:21.38%
419
2727
974
10928
201
962
1192
12693
34
115
1359
13540
—
34
131
1359
13513
196
973
1180
12508
424
2727
889
10025
CT of paranasal sinuses and face area
DM1AD [2001301741]
1.8e+00
—
—
—
—
2.9e+00
—
cases:0.79%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.04%
—
—
11
18
1382
13637
—
—
—
—
9
5
1367
13476
—
Plastic And Reconstructive Surgery
24 [38004467]
7.8e-01
1.2e+00
1.5e+00
1.0e+50
1.9e+00
1.6e+00
1.1e+00
cases:2.66%
controls:1.23%
cases:1.65%
controls:0.49%
cases:0.36%
controls:0.08%
cases:2.15%
controls:0.00%
cases:0.43%
controls:0.07%
cases:2.47%
controls:0.53%
cases:4.34%
controls:1.50%
37
168
1356
13487
23
67
1370
13588
5
11
1388
13644
30
0
1363
13655
6
9
1387
13635
34
71
1342
13410
57
191
1256
12561
Oral Surgery
19 [38004464]
7.5e-01
1.9e+00
—
—
—
1.6e+00
1.1e+00
cases:1.29%
controls:0.62%
cases:0.79%
controls:0.12%
—
—
—
—
—
—
cases:0.87%
controls:0.19%
cases:1.75%
controls:0.56%
18
84
1375
13571
11
17
1382
13638
—
—
—
12
25
1364
13456
23
72
1290
12680
Seropositive rheumatoid arthritis, unspecified
M05.9 [45553050]
2.8e+00
—
—
—
—
—
1.7e+00
cases:1.08%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.13%
15
9
1378
13646
—
—
—
—
—
9
16
1304
12736
Physical abuse
T74.1 [45594864]
1.8e+00
2.6e+00
—
—
—
—
1.7e+00
cases:0.65%
controls:0.10%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.09%
9
14
1384
13641
7
5
1386
13650
—
—
—
—
7
12
1306
12740
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
1.1e+00
1.8e+00
—
—
—
—
1.5e+00
cases:0.93%
controls:0.31%
cases:0.57%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.38%
13
42
1380
13613
8
13
1385
13642
—
—
—
—
22
48
1291
12704
hydroxychloroquine; oral
P01BA02 [21604889]
1.0e+00
1.1e+00
1.2e+00
—
—
1.1e+00
1.2e+00
cases:1.65%
controls:0.59%
cases:1.22%
controls:0.42%
cases:0.36%
controls:0.11%
—
—
—
—
cases:1.24%
controls:0.40%
cases:1.98%
controls:0.63%
23
80
1370
13575
17
58
1376
13597
5
15
1388
13640
—
—
17
54
1359
13427
26
80
1287
12672
Exposure to unspecified factor
X59 [45756412]
8.9e-01
1.2e+00
—
—
—
1.3e+00
1.0e+00
cases:3.16%
controls:1.33%
cases:1.44%
controls:0.45%
—
—
—
—
—
—
cases:1.38%
controls:0.39%
cases:4.27%
controls:1.59%
44
181
1349
13474
20
61
1373
13594
—
—
—
19
52
1357
13429
56
203
1257
12549
Case Management Agency
251B00000X [38004193]
4.7e-02
2.0e-01
4.9e-01
3.2e+00
4.7e-01
2.3e-01
1.6e-01
cases:32.74%
controls:31.70%
cases:29.94%
controls:25.92%
cases:14.93%
controls:9.72%
cases:12.85%
controls:0.62%
cases:14.29%
controls:9.46%
cases:32.63%
controls:27.79%
cases:48.74%
controls:44.77%
456
4329
937
9326
417
3539
976
10116
208
1327
1185
12328
179
84
1214
13571
199
1291
1194
12353
449
3746
927
9735
640
5709
673
7043
Sensorineural hearing loss, bilateral
H90.3 [45576850]
1.1e+00
1.3e+00
—
—
—
1.1e+00
9.0e-01
cases:2.30%
controls:0.76%
cases:1.01%
controls:0.29%
—
—
—
—
—
—
cases:1.16%
controls:0.41%
cases:3.05%
controls:1.26%
32
104
1361
13551
14
39
1379
13616
—
—
—
16
55
1360
13426
40
161
1273
12591
Supplier / Service Provider
OMOP5117446 [33004]
-1.6e+00
-1.1e+00
-8.1e-01
—
—
3.3e+00
3.7e+00
cases:8.04%
controls:29.66%
cases:3.66%
controls:10.67%
cases:0.50%
controls:1.12%
—
—
—
—
cases:3.42%
controls:0.13%
cases:10.97%
controls:0.30%
112
4050
1281
9605
51
1457
1342
12198
7
153
1386
13502
—
—
47
17
1329
13464
144
38
1169
12714
Sedation and analgesia
WX002 [2001310758]
9.0e-01
1.2e+00
—
—
—
2.1e+00
1.4e+00
cases:2.23%
controls:0.92%
cases:0.86%
controls:0.26%
—
—
—
—
—
—
cases:1.45%
controls:0.19%
cases:3.35%
controls:0.89%
31
125
1362
13530
12
36
1381
13619
—
—
—
20
25
1356
13456
44
113
1269
12639
fluticasone, combinations
R01AD58 [43534837]
1.0e+00
1.0e+00
1.5e+00
—
1.2e+00
8.2e-01
4.9e-01
cases:4.59%
controls:1.73%
cases:2.80%
controls:1.05%
cases:0.65%
controls:0.15%
—
—
cases:0.43%
controls:0.12%
cases:2.03%
controls:0.90%
cases:3.88%
controls:2.42%
64
236
1329
13419
39
143
1354
13512
9
20
1384
13635
—
6
17
1387
13627
28
122
1348
13359
51
309
1262
12443
azelastine; nasal
R01AC03 [21605035]
9.9e-01
1.0e+00
1.5e+00
—
1.2e+00
8.2e-01
4.8e-01
cases:4.59%
controls:1.75%
cases:2.80%
controls:1.05%
cases:0.65%
controls:0.15%
—
—
cases:0.43%
controls:0.12%
cases:2.03%
controls:0.90%
cases:3.88%
controls:2.44%
64
239
1329
13416
39
143
1354
13512
9
20
1384
13635
—
6
17
1387
13627
28
122
1348
13359
51
311
1262
12441
sulfadiazine and trimethoprim
J01EE02 [21602962]
7.0e-01
9.5e-01
—
—
2.0e+00
6.7e-01
6.3e-01
cases:4.52%
controls:2.29%
cases:1.58%
controls:0.62%
—
—
—
—
cases:0.43%
controls:0.06%
cases:1.38%
controls:0.71%
cases:4.34%
controls:2.37%
63
313
1330
13342
22
84
1371
13571
—
—
6
8
1387
13636
19
96
1357
13385
57
302
1256
12450
Medical doctor
Z2221 [2001311556]
7.1e-01
1.1e+00
1.5e+00
—
9.0e-01
1.3e+00
1.1e+00
cases:4.95%
controls:2.49%
cases:2.87%
controls:0.96%
cases:0.57%
controls:0.13%
—
—
cases:0.36%
controls:0.15%
cases:2.98%
controls:0.79%
cases:6.02%
controls:2.15%
69
340
1324
13315
40
131
1353
13524
8
18
1385
13637
—
5
20
1388
13624
41
107
1335
13374
79
274
1234
12478
Acute maxillary sinusitis
J01.0 [45601112]
9.3e-01
1.4e+00
—
—
—
1.1e+00
8.6e-01
cases:3.37%
controls:1.35%
cases:2.15%
controls:0.56%
—
—
—
—
—
—
cases:1.74%
controls:0.61%
cases:4.72%
controls:2.05%
47
185
1346
13470
30
77
1363
13578
—
—
—
24
82
1352
13399
62
261
1251
12491
Telehealth
OMOP5556618 [722455]
3.4e-01
5.7e-01
1.3e+00
—
9.1e-01
6.5e-01
4.5e-01
cases:12.78%
controls:9.42%
cases:7.54%
controls:4.39%
cases:2.44%
controls:0.70%
—
—
cases:1.65%
controls:0.67%
cases:7.63%
controls:4.15%
cases:17.14%
controls:11.62%
178
1286
1215
12369
105
599
1288
13056
34
96
1359
13559
—
23
92
1370
13552
105
559
1271
12922
225
1482
1088
11270
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
8.3e-01
1.5e+00
—
—
1.4e+00
1.5e+00
1.2e+00
cases:0.72%
controls:0.31%
cases:0.79%
controls:0.18%
—
—
—
—
cases:0.36%
controls:0.09%
cases:0.65%
controls:0.15%
cases:1.29%
controls:0.40%
10
43
1383
13612
11
25
1382
13630
—
—
5
12
1388
13632
9
20
1367
13461
17
51
1296
12701
Predominantly allergic asthma
J45.0 [45557624]
9.6e-01
1.2e+00
—
—
—
1.1e+00
7.7e-01
cases:2.08%
controls:0.81%
cases:1.36%
controls:0.40%
—
—
—
—
—
—
cases:1.16%
controls:0.38%
cases:1.98%
controls:0.93%
29
110
1364
13545
19
55
1374
13600
—
—
—
16
51
1360
13430
26
118
1287
12634
zolpidem; oral
N05CF02 [21604655]
9.3e-01
1.1e+00
1.2e+00
—
7.6e-01
1.0e+00
1.1e+00
cases:4.16%
controls:1.69%
cases:2.73%
controls:0.96%
cases:0.79%
controls:0.23%
—
—
cases:0.50%
controls:0.23%
cases:2.62%
controls:0.95%
cases:5.26%
controls:1.89%
58
231
1335
13424
38
131
1355
13524
11
32
1382
13623
—
7
32
1386
13612
36
128
1340
13353
69
241
1244
12511
General Practice Dentistry
1223G0001X [38003675]
1.2e+00
1.6e+00
—
—
-1.0e+50
1.6e+00
1.2e+00
cases:0.93%
controls:0.29%
cases:0.57%
controls:0.12%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.87%
controls:0.17%
cases:1.29%
controls:0.38%
13
39
1380
13616
8
16
1385
13639
—
—
0
5
1393
13639
12
23
1364
13458
17
48
1296
12704
budesonide; inhalant
R03BA02 [21603285]
5.9e-01
7.5e-01
5.8e-01
—
1.2e+00
7.3e-01
7.2e-01
cases:5.67%
controls:3.23%
cases:3.73%
controls:1.80%
cases:0.86%
controls:0.48%
—
—
cases:1.08%
controls:0.32%
cases:3.71%
controls:1.82%
cases:7.54%
controls:3.80%
79
441
1314
13214
52
246
1341
13409
12
66
1381
13589
—
15
43
1378
13601
51
246
1325
13235
99
485
1214
12267
Ankle X-ray examination without contrast
NH1AA [2001308235]
—
1.8e+00
—
—
—
2.2e+00
4.5e-01
—
—
cases:0.65%
controls:0.10%
—
—
—
—
—
—
cases:0.58%
controls:0.07%
cases:0.76%
controls:0.49%
—
9
14
1384
13641
—
—
—
8
9
1368
13472
10
62
1303
12690
fluconazole; oral, parenteral
J02AC01 [21603080]
4.0e-01
6.2e-01
8.1e-01
—
1.7e+00
7.0e-01
6.3e-01
cases:6.75%
controls:4.61%
cases:2.94%
controls:1.61%
cases:0.57%
controls:0.26%
—
—
cases:0.57%
controls:0.11%
cases:2.76%
controls:1.39%
cases:8.30%
controls:4.60%
94
629
1299
13026
41
220
1352
13435
8
35
1385
13620
—
8
15
1385
13629
38
187
1338
13294
109
587
1204
12165
Bilateral
ZXA10 [2001311348]
1.1e+00
1.1e+00
—
1.0e+50
—
2.1e+00
7.9e-01
cases:2.58%
controls:0.85%
cases:0.93%
controls:0.30%
—
—
cases:0.65%
controls:0.00%
—
—
cases:1.60%
controls:0.21%
cases:2.44%
controls:1.12%
36
116
1357
13539
13
41
1380
13614
—
9
0
1384
13655
—
22
28
1354
13453
32
143
1281
12609
Intravenous general anesthesia
WX404 [2001310807]
6.5e-01
1.1e+00
—
—
—
1.8e+00
1.1e+00
cases:2.30%
controls:1.21%
cases:0.93%
controls:0.31%
—
—
—
—
—
—
cases:1.38%
controls:0.24%
cases:2.59%
controls:0.89%
32
165
1361
13490
13
43
1380
13612
—
—
—
19
32
1357
13449
34
114
1279
12638
Neurosurgery
14 [38004459]
8.9e-01
9.6e-01
-1.0e+50
1.0e+50
1.7e+00
1.0e+00
1.1e+00
cases:3.23%
controls:1.35%
cases:1.29%
controls:0.50%
cases:0.00%
controls:0.07%
cases:0.43%
controls:0.00%
cases:0.50%
controls:0.10%
cases:1.24%
controls:0.45%
cases:4.04%
controls:1.44%
45
184
1348
13471
18
68
1375
13587
0
9
1393
13646
6
0
1387
13655
7
13
1386
13631
17
60
1359
13421
53
184
1260
12568
Intubation
WX704 [2001310820]
4.9e-01
1.2e+00
—
—
—
2.3e+00
1.6e+00
cases:0.79%
controls:0.48%
cases:0.43%
controls:0.12%
—
—
—
—
—
—
cases:1.31%
controls:0.13%
cases:1.83%
controls:0.36%
11
66
1382
13589
6
17
1387
13638
—
—
—
18
18
1358
13463
24
46
1289
12706
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
9.3e-01
1.2e+00
—
—
—
1.6e+00
1.3e+00
cases:1.22%
controls:0.48%
cases:0.57%
controls:0.18%
—
—
—
—
—
—
cases:0.80%
controls:0.16%
cases:2.21%
controls:0.60%
17
66
1376
13589
8
24
1385
13631
—
—
—
11
21
1365
13460
29
76
1284
12676
clonazepam; oral, parenteral
N03AE01 [21604415]
8.7e-01
1.0e+00
—
—
1.3e+00
9.5e-01
1.0e+00
cases:1.44%
controls:0.61%
cases:1.15%
controls:0.41%
—
—
—
—
cases:0.43%
controls:0.12%
cases:1.16%
controls:0.45%
cases:1.98%
controls:0.71%
20
83
1373
13572
16
56
1377
13599
—
—
6
16
1387
13628
16
61
1360
13420
26
90
1287
12662
Audiology
64 [38004489]
6.7e-01
1.3e+00
—
—
—
1.4e+00
1.2e+00
cases:1.87%
controls:0.96%
cases:1.29%
controls:0.37%
—
—
—
—
—
—
cases:1.89%
controls:0.47%
cases:3.88%
controls:1.18%
26
131
1367
13524
18
50
1375
13605
—
—
—
26
63
1350
13418
51
151
1262
12601
Dyspnoea
R06.0 [45558449]
9.4e-01
9.9e-01
—
—
—
9.3e-01
9.8e-01
cases:3.23%
controls:1.28%
cases:1.29%
controls:0.48%
—
—
—
—
—
—
cases:1.31%
controls:0.52%
cases:4.95%
controls:1.91%
45
175
1348
13480
18
66
1375
13589
—
—
—
18
70
1358
13411
65
244
1248
12508
Own respiration
WX720 [2001310823]
—
—
—
—
—
2.3e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.06%
cases:0.84%
controls:0.18%
—
—
—
—
—
8
8
1368
13473
11
23
1302
12729
esomeprazole; oral, parenteral
A02BC05 [21600100]
6.0e-01
6.4e-01
8.6e-01
—
1.2e+00
6.9e-01
7.1e-01
cases:7.39%
controls:4.20%
cases:3.80%
controls:2.04%
cases:0.93%
controls:0.40%
—
—
cases:1.22%
controls:0.38%
cases:4.29%
controls:2.20%
cases:9.60%
controls:4.96%
103
574
1290
13081
53
278
1340
13377
13
54
1380
13601
—
17
52
1376
13592
59
297
1317
13184
126
633
1187
12119
amoxicillin; oral, parenteral
J01CA04 [21602823]
4.7e-01
7.9e-01
6.2e-01
—
1.3e+00
7.8e-01
4.8e-01
cases:21.61%
controls:14.68%
cases:9.55%
controls:4.56%
cases:1.01%
controls:0.54%
—
—
cases:1.51%
controls:0.43%
cases:9.30%
controls:4.47%
cases:24.30%
controls:16.63%
301
2005
1092
11650
133
622
1260
13033
14
74
1379
13581
—
21
58
1372
13586
128
603
1248
12878
319
2121
994
10631
Cervical spine CT examination
NA1AD [2001306982]
—
2.3e+00
—
—
—
—
1.5e+00
—
—
cases:0.43%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.20%
—
6
6
1387
13649
—
—
—
—
12
26
1301
12726
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
4.0e-01
3.0e-01
2.1e+00
—
—
8.7e-01
7.5e-01
cases:4.38%
controls:2.99%
cases:1.51%
controls:1.12%
cases:0.43%
controls:0.05%
—
—
—
—
cases:2.11%
controls:0.90%
cases:7.54%
controls:3.70%
61
408
1332
13247
21
153
1372
13502
6
7
1387
13648
—
—
29
121
1347
13360
99
472
1214
12280
Dental impressions
SBB10 [2001310299]
9.5e-01
—
—
—
—
1.8e+00
9.8e-01
cases:1.29%
controls:0.51%
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.10%
cases:1.22%
controls:0.46%
18
69
1375
13586
—
—
—
—
8
13
1368
13468
16
59
1297
12693
Asthma, unspecified
J45.9 [45562456]
6.5e-01
1.2e+00
—
—
—
9.9e-01
8.4e-01
cases:2.44%
controls:1.29%
cases:1.87%
controls:0.56%
—
—
—
—
—
—
cases:1.74%
controls:0.65%
cases:4.04%
controls:1.79%
34
176
1359
13479
26
76
1367
13579
—
—
—
24
88
1352
13393
53
228
1260
12524
Monitoring the use of the aid
R5140 [2001310249]
6.4e-01
1.3e+00
—
—
-1.0e+50
1.2e+00
1.2e+00
cases:0.86%
controls:0.45%
cases:0.93%
controls:0.26%
—
—
—
—
cases:0.00%
controls:0.05%
cases:1.02%
controls:0.30%
cases:1.90%
controls:0.59%
12
62
1381
13593
13
36
1380
13619
—
—
0
7
1393
13637
14
41
1362
13440
25
75
1288
12677
gabapentin; oral
N02BF01 [955005]
1.0e+00
9.0e-01
1.4e+00
—
1.3e+00
8.9e-01
8.2e-01
cases:2.51%
controls:0.91%
cases:1.36%
controls:0.56%
cases:0.43%
controls:0.10%
—
—
cases:0.65%
controls:0.18%
cases:1.53%
controls:0.63%
cases:3.73%
controls:1.68%
35
124
1358
13531
19
76
1374
13579
6
14
1387
13641
—
9
24
1384
13620
21
85
1355
13396
49
214
1264
12538
cetirizine; oral
R06AE07 [21603497]
5.6e-01
6.5e-01
1.1e+00
-1.0e+50
5.7e-01
6.6e-01
5.8e-01
cases:9.55%
controls:5.67%
cases:4.95%
controls:2.64%
cases:1.08%
controls:0.34%
cases:0.00%
controls:0.04%
cases:0.65%
controls:0.37%
cases:4.94%
controls:2.62%
cases:10.51%
controls:6.19%
133
774
1260
12881
69
360
1324
13295
15
47
1378
13608
0
6
1393
13649
9
50
1384
13594
68
353
1308
13128
138
789
1175
11963
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.1e+00
1.4e+00
—
—
—
1.4e+00
1.0e+00
cases:1.51%
controls:0.48%
cases:0.65%
controls:0.15%
—
—
—
—
—
—
cases:0.73%
controls:0.18%
cases:1.45%
controls:0.52%
21
66
1372
13589
9
21
1384
13634
—
—
—
10
24
1366
13457
19
66
1294
12686
Loss of teeth due to accident, extraction or local periodontal disease
K08.1 [45591573]
1.1e+00
1.1e+00
—
—
—
1.7e+00
7.7e-01
cases:1.08%
controls:0.35%
cases:0.57%
controls:0.19%
—
—
—
—
—
—
cases:0.80%
controls:0.15%
cases:1.83%
controls:0.85%
15
48
1378
13607
8
26
1385
13629
—
—
—
11
20
1365
13461
24
109
1289
12643
Other minor procedure in surgery of ear, nose and larynx
TDW99 [2001301879]
1.5e+00
—
—
1.0e+50
—
—
2.1e+00
cases:0.72%
controls:0.17%
—
—
—
—
cases:0.43%
controls:0.00%
—
—
—
—
cases:0.91%
controls:0.11%
10
23
1383
13632
—
—
6
0
1387
13655
—
—
12
14
1301
12738
Pharmacy visit
OMOP4822462 [581458]
4.5e-02
4.1e-01
4.4e-01
1.5e+00
8.1e-01
4.1e-01
2.5e-01
cases:70.42%
controls:69.48%
cases:67.91%
controls:58.29%
cases:34.82%
controls:25.55%
cases:5.74%
controls:1.34%
cases:43.43%
controls:25.51%
cases:69.99%
controls:60.69%
cases:84.46%
controls:80.82%
981
9488
412
4167
946
7960
447
5695
485
3489
908
10166
80
183
1313
13472
605
3480
788
10164
963
8181
413
5300
1109
10306
204
2446
General anaesthesia
WX402 [2001310806]
2.4e-01
9.0e-01
—
—
—
2.2e+00
1.4e+00
cases:0.86%
controls:0.68%
cases:0.93%
controls:0.38%
—
—
—
—
—
—
cases:2.98%
controls:0.33%
cases:3.66%
controls:0.97%
12
93
1381
13562
13
52
1380
13603
—
—
—
41
45
1335
13436
48
124
1265
12628
Functional endoscopic opening of maxillary antrum
DMB20 [2001301780]
1.2e+00
—
—
—
—
2.4e+00
9.2e-01
cases:1.01%
controls:0.31%
—
—
—
—
—
—
—
—
cases:0.80%
controls:0.07%
cases:0.84%
controls:0.34%
14
43
1379
13612
—
—
—
—
11
10
1365
13471
11
43
1302
12709
Nausea and vomiting
R11 [45539317]
6.8e-01
—
—
—
—
2.4e+00
1.1e+00
cases:0.57%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.05%
cases:1.14%
controls:0.38%
8
40
1385
13615
—
—
—
—
8
7
1368
13474
15
48
1298
12704
doxycycline; oral, parenteral
J01AA02 [21602800]
4.2e-01
7.0e-01
7.1e-01
1.0e+50
1.3e+00
6.8e-01
3.8e-01
cases:19.53%
controls:13.76%
cases:8.11%
controls:4.20%
cases:1.08%
controls:0.53%
cases:0.36%
controls:0.00%
cases:1.72%
controls:0.46%
cases:8.79%
controls:4.64%
cases:21.17%
controls:15.53%
272
1879
1121
11776
113
573
1280
13082
15
73
1378
13582
5
0
1388
13655
24
63
1369
13581
121
625
1255
12856
278
1981
1035
10771
doxepin; oral, parenteral
N06AA12 [21604699]
9.2e-01
1.2e+00
2.3e+00
—
—
1.5e+00
1.1e+00
cases:1.22%
controls:0.49%
cases:0.57%
controls:0.18%
cases:0.36%
controls:0.04%
—
—
—
—
cases:0.73%
controls:0.16%
cases:1.45%
controls:0.50%
17
67
1376
13588
8
24
1385
13631
5
5
1388
13650
—
—
10
22
1366
13459
19
64
1294
12688
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
313 [2001600274]
1.6e+00
—
—
—
—
—
1.8e+00
cases:0.65%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.11%
9
18
1384
13637
—
—
—
—
—
9
14
1304
12738
Knee X-ray examination without contrast
NG1AA [2001308049]
1.0e+00
—
—
—
—
1.4e+00
9.9e-01
cases:1.15%
controls:0.42%
—
—
—
—
—
—
—
—
cases:0.87%
controls:0.22%
cases:1.45%
controls:0.54%
16
58
1377
13597
—
—
—
—
12
29
1364
13452
19
69
1294
12683
Noninvasive ventilation
WX725 [2001310828]
—
—
—
—
—
1.8e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.12%
cases:1.14%
controls:0.25%
—
—
—
—
—
10
16
1366
13465
15
32
1298
12720
Other healthcare associate professional
Z3229 [2001311561]
1.2e-01
1.1e+00
—
—
—
1.8e+00
1.5e+00
cases:0.43%
controls:0.38%
cases:0.50%
controls:0.17%
—
—
—
—
—
—
cases:0.73%
controls:0.12%
cases:1.90%
controls:0.42%
6
52
1387
13603
7
23
1386
13632
—
—
—
10
16
1366
13465
25
54
1288
12698
clindamycin; oral, parenteral
J01FF01 [21602985]
4.0e-01
6.0e-01
—
—
2.2e+00
1.1e+00
4.9e-01
cases:3.30%
controls:2.23%
cases:1.22%
controls:0.67%
—
—
—
—
cases:0.65%
controls:0.07%
cases:1.89%
controls:0.62%
cases:4.27%
controls:2.66%
46
305
1347
13350
17
92
1376
13563
—
—
9
10
1384
13634
26
84
1350
13397
56
339
1257
12413
lactulose; oral
A06AD11 [21600571]
1.2e+00
9.0e-01
—
—
—
1.3e+00
8.5e-01
cases:1.87%
controls:0.57%
cases:0.86%
controls:0.35%
—
—
—
—
—
—
cases:1.09%
controls:0.31%
cases:2.36%
controls:1.03%
26
78
1367
13577
12
48
1381
13607
—
—
—
15
42
1361
13439
31
131
1282
12621
mirtazapine; oral
N06AX11 [21604740]
7.0e-01
7.4e-01
9.0e-01
—
5.9e-01
1.1e+00
7.8e-01
cases:5.67%
controls:2.89%
cases:3.02%
controls:1.46%
cases:0.86%
controls:0.35%
—
—
cases:0.65%
controls:0.36%
cases:4.29%
controls:1.54%
cases:8.15%
controls:3.89%
79
394
1314
13261
42
199
1351
13456
12
48
1381
13607
—
9
49
1384
13595
59
208
1317
13273
107
496
1206
12256
etoricoxib; oral
M01AH05 [21603996]
4.3e-01
5.6e-01
1.1e+00
—
6.2e-01
5.7e-01
6.1e-01
cases:10.12%
controls:6.82%
cases:4.88%
controls:2.85%
cases:1.08%
controls:0.36%
—
—
cases:0.79%
controls:0.43%
cases:5.23%
controls:3.02%
cases:15.08%
controls:8.80%
141
931
1252
12724
68
389
1325
13266
15
49
1378
13606
—
11
58
1382
13586
72
407
1304
13074
198
1122
1115
11630
citalopram; oral, parenteral
N06AB04 [21604712]
7.9e-01
8.4e-01
8.6e-02
—
8.3e-01
8.1e-01
8.2e-01
cases:4.45%
controls:2.08%
cases:2.58%
controls:1.13%
cases:0.36%
controls:0.33%
—
—
cases:0.72%
controls:0.32%
cases:2.62%
controls:1.18%
cases:5.64%
controls:2.56%
62
284
1331
13371
36
154
1357
13501
5
45
1388
13610
—
10
43
1383
13601
36
159
1340
13322
74
327
1239
12425
cefadroxil; oral
J01DB05 [21602874]
2.9e-01
8.3e-01
—
—
3.2e+00
6.5e-01
1.9e-01
cases:2.73%
controls:2.06%
cases:0.93%
controls:0.41%
—
—
—
—
cases:0.93%
controls:0.04%
cases:0.94%
controls:0.50%
cases:2.21%
controls:1.83%
38
281
1355
13374
13
56
1380
13599
—
—
13
5
1380
13639
13
67
1363
13414
29
233
1284
12519
Depressive episode, unspecified
F32.9 [45571760]
5.8e-01
1.3e+00
—
—
—
1.1e+00
8.6e-01
cases:1.72%
controls:0.97%
cases:1.29%
controls:0.37%
—
—
—
—
—
—
cases:1.24%
controls:0.40%
cases:2.82%
controls:1.22%
24
133
1369
13522
18
51
1375
13604
—
—
—
17
54
1359
13427
37
155
1276
12597
Thorax X-ray examination
GD1AA [2001303617]
7.1e-01
6.9e-01
1.4e+00
—
1.0e+00
8.8e-01
9.4e-01
cases:5.31%
controls:2.69%
cases:2.23%
controls:1.13%
cases:0.36%
controls:0.09%
—
—
cases:0.36%
controls:0.13%
cases:2.54%
controls:1.08%
cases:8.76%
controls:3.63%
74
367
1319
13288
31
154
1362
13501
5
12
1388
13643
—
5
18
1388
13626
35
145
1341
13336
115
463
1198
12289
Rehabilitation Hospital
283X00000X [38004285]
1.3e+00
1.9e+00
—
—
—
—
6.4e-01
cases:1.01%
controls:0.29%
cases:0.50%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.28%
14
39
1379
13616
7
10
1386
13645
—
—
—
—
7
36
1306
12716
duloxetine; oral
N06AX21 [21604749]
9.2e-01
1.2e+00
—
—
—
7.6e-01
1.0e+00
cases:1.51%
controls:0.61%
cases:1.01%
controls:0.30%
—
—
—
—
—
—
cases:0.87%
controls:0.41%
cases:2.28%
controls:0.82%
21
83
1372
13572
14
41
1379
13614
—
—
—
12
55
1364
13426
30
104
1283
12648
Headache
R51.80 [2000503603]
8.5e-01
1.2e+00
—
—
-1.0e+50
8.1e-01
1.1e+00
cases:1.87%
controls:0.81%
cases:0.86%
controls:0.26%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.58%
controls:0.26%
cases:3.05%
controls:1.04%
26
110
1367
13545
12
35
1381
13620
—
—
0
5
1393
13639
8
35
1368
13446
40
132
1273
12620
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
1.2e+00
1.1e+00
—
—
—
2.0e+00
7.6e-01
cases:1.51%
controls:0.46%
cases:0.50%
controls:0.16%
—
—
—
—
—
—
cases:1.09%
controls:0.16%
cases:1.29%
controls:0.61%
21
63
1372
13592
7
22
1386
13633
—
—
—
15
21
1361
13460
17
78
1296
12674
prednisolone
A07EA01 [21600653]
7.4e-01
8.8e-01
7.9e-01
—
8.3e-01
6.7e-01
8.4e-01
cases:9.76%
controls:4.91%
cases:5.10%
controls:2.18%
cases:0.65%
controls:0.29%
—
—
cases:0.72%
controls:0.32%
cases:4.43%
controls:2.32%
cases:13.10%
controls:6.12%
136
670
1257
12985
71
297
1322
13358
9
40
1384
13615
—
10
43
1383
13601
61
313
1315
13168
172
780
1141
11972
prednisolone; oral, parenteral
H02AB06 [21602734]
7.5e-01
8.9e-01
7.9e-01
—
8.3e-01
6.5e-01
8.3e-01
cases:9.76%
controls:4.87%
cases:5.10%
controls:2.17%
cases:0.65%
controls:0.29%
—
—
cases:0.72%
controls:0.32%
cases:4.36%
controls:2.31%
cases:13.02%
controls:6.11%
136
665
1257
12990
71
296
1322
13359
9
40
1384
13615
—
10
43
1383
13601
60
312
1316
13169
171
779
1142
11973
Abdominal pain localized other
D06 [2002000305]
6.9e-01
1.3e+00
—
—
—
1.9e+00
1.2e+00
cases:0.93%
controls:0.47%
cases:0.43%
controls:0.12%
—
—
—
—
—
—
cases:0.58%
controls:0.09%
cases:1.52%
controls:0.45%
13
64
1380
13591
6
16
1387
13639
—
—
—
8
12
1368
13469
20
57
1293
12695
hydroxyzine; oral, parenteral
N05BB01 [21604590]
7.0e-01
1.5e+00
1.9e+00
—
1.7e+00
1.6e+00
4.9e-01
cases:1.94%
controls:0.97%
cases:1.22%
controls:0.29%
cases:0.43%
controls:0.07%
—
—
cases:0.36%
controls:0.07%
cases:1.60%
controls:0.31%
cases:1.98%
controls:1.22%
27
133
1366
13522
17
39
1376
13616
6
9
1387
13646
—
5
9
1388
13635
22
42
1354
13439
26
156
1287
12596
Right side
ZXA00 [2001311346]
6.7e-01
6.6e-01
—
—
—
1.5e+00
8.6e-01
cases:2.94%
controls:1.53%
cases:0.79%
controls:0.41%
—
—
—
—
—
—
cases:1.89%
controls:0.42%
cases:4.19%
controls:1.81%
41
209
1352
13446
11
56
1382
13599
—
—
—
26
56
1350
13425
55
231
1258
12521
12 lead EKG panel
34534-8 [3044889]
4.0e-01
4.7e-01
1.0e+00
—
3.6e-01
7.3e-01
4.3e-01
cases:7.61%
controls:5.25%
cases:4.45%
controls:2.83%
cases:1.01%
controls:0.36%
—
—
cases:0.43%
controls:0.30%
cases:5.38%
controls:2.66%
cases:13.02%
controls:8.91%
106
717
1287
12938
62
387
1331
13268
14
49
1379
13606
—
6
41
1387
13603
74
359
1302
13122
171
1136
1142
11616
Laceration/cut
S18 [2002000983]
5.8e-01
9.7e-01
1.0e+00
—
1.7e+00
8.5e-01
6.0e-01
cases:4.38%
controls:2.50%
cases:2.51%
controls:0.97%
cases:0.36%
controls:0.13%
—
—
cases:0.50%
controls:0.09%
cases:2.33%
controls:1.01%
cases:6.85%
controls:3.90%
61
341
1332
13314
35
132
1358
13523
5
18
1388
13637
—
7
12
1386
13632
32
136
1344
13345
90
497
1223
12255
pantoprazole; oral, parenteral
A02BC02 [21600097]
4.2e-01
4.7e-01
-8.8e-02
—
7.8e-01
6.6e-01
6.5e-01
cases:10.41%
controls:7.10%
cases:6.25%
controls:3.99%
cases:0.72%
controls:0.78%
—
—
cases:1.79%
controls:0.83%
cases:7.56%
controls:4.05%
cases:17.21%
controls:9.79%
145
969
1248
12686
87
545
1306
13110
10
107
1383
13548
—
25
113
1368
13531
104
546
1272
12935
226
1249
1087
11503
Respiratory and circulatory monitoring
WX700 [2001310817]
2.6e-01
7.0e-01
—
—
—
1.7e+00
1.3e+00
cases:1.29%
controls:1.00%
cases:0.57%
controls:0.29%
—
—
—
—
—
—
cases:1.38%
controls:0.25%
cases:3.12%
controls:0.90%
18
137
1375
13518
8
39
1385
13616
—
—
—
19
34
1357
13447
41
115
1272
12637
fenoterol and ipratropium bromide
R03AL01 [43534843]
9.0e-01
1.3e+00
—
—
—
1.8e+00
1.1e+00
cases:0.57%
controls:0.23%
cases:0.43%
controls:0.12%
—
—
—
—
—
—
cases:0.51%
controls:0.08%
cases:0.99%
controls:0.32%
8
32
1385
13623
6
16
1387
13639
—
—
—
7
11
1369
13470
13
41
1300
12711
fluoxetine; oral
N06AB03 [21604711]
9.7e-01
9.7e-01
—
—
—
4.3e-01
1.0e+00
cases:2.80%
controls:1.08%
cases:1.36%
controls:0.52%
—
—
—
—
—
—
cases:0.87%
controls:0.57%
cases:3.27%
controls:1.22%
39
148
1354
13507
19
71
1374
13584
—
—
—
12
77
1364
13404
43
155
1270
12597
Cathetrisation of vein
TPH04 [2001309597]
-7.4e-03
9.2e-01
-1.0e+50
—
—
1.8e+00
1.1e+00
cases:1.15%
controls:1.16%
cases:1.01%
controls:0.40%
cases:0.00%
controls:0.08%
—
—
—
—
cases:1.74%
controls:0.28%
cases:3.66%
controls:1.23%
16
158
1377
13497
14
55
1379
13600
0
11
1393
13644
—
—
24
38
1352
13443
48
157
1265
12595
Addiction caused by alcohol UNS
F10.29 [2000501684]
1.4e+00
—
—
—
—
—
1.5e+00
cases:0.72%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.16%
10
24
1383
13631
—
—
—
—
—
10
21
1303
12731
Psychiatry
26 [38004469]
6.7e-01
8.2e-01
7.2e-01
—
4.8e-01
6.7e-01
7.7e-01
cases:7.61%
controls:4.06%
cases:4.81%
controls:2.18%
cases:1.72%
controls:0.85%
—
—
cases:1.44%
controls:0.89%
cases:4.00%
controls:2.08%
cases:9.52%
controls:4.64%
106
554
1287
13101
67
297
1326
13358
24
116
1369
13539
—
20
122
1373
13522
55
280
1321
13201
125
592
1188
12160
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
1.2e+00
1.7e+00
—
—
—
1.3e+00
6.6e-01
cases:0.93%
controls:0.28%
cases:0.65%
controls:0.12%
—
—
—
—
—
—
cases:0.51%
controls:0.14%
cases:1.22%
controls:0.64%
13
38
1380
13617
9
16
1384
13639
—
—
—
7
19
1369
13462
16
81
1297
12671
Ear microscopy
UDC00 [2001301558]
8.6e-01
1.8e+00
—
—
—
1.3e+00
1.1e+00
cases:0.86%
controls:0.37%
cases:0.65%
controls:0.10%
—
—
—
—
—
—
cases:0.58%
controls:0.16%
cases:1.07%
controls:0.37%
12
50
1381
13605
9
14
1384
13641
—
—
—
8
22
1368
13459
14
47
1299
12705
piroxicam; ointment
M02AA07 [21604043]
4.8e-01
8.9e-01
1.4e+00
—
—
8.1e-01
7.4e-01
cases:4.81%
controls:3.02%
cases:1.87%
controls:0.78%
cases:0.43%
controls:0.10%
—
—
—
—
cases:2.03%
controls:0.92%
cases:6.55%
controls:3.25%
67
412
1326
13243
26
106
1367
13549
6
14
1387
13641
—
—
28
124
1348
13357
86
414
1227
12338
tibolone; oral
G03CX01 [21602536]
1.6e+00
1.3e+00
—
—
—
1.2e+00
1.3e+00
cases:0.86%
controls:0.18%
cases:0.43%
controls:0.12%
—
—
—
—
—
—
cases:0.36%
controls:0.11%
cases:0.84%
controls:0.22%
12
25
1381
13630
6
16
1387
13639
—
—
—
5
15
1371
13466
11
28
1302
12724
Lumbago with sciatica
M54.4 [45553205]
8.7e-01
1.2e+00
-1.0e+50
—
—
7.8e-01
8.2e-01
cases:2.15%
controls:0.92%
cases:1.01%
controls:0.31%
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.87%
controls:0.40%
cases:3.05%
controls:1.36%
30
125
1363
13530
14
43
1379
13612
0
8
1393
13647
—
—
12
54
1364
13427
40
174
1273
12578
Hypersensitivity skin testing
268377001 [4147813]
—
1.1e+00
—
—
—
1.8e+00
9.5e-01
—
—
cases:0.36%
controls:0.12%
—
—
—
—
—
—
cases:0.65%
controls:0.10%
cases:1.37%
controls:0.53%
—
5
16
1388
13639
—
—
—
9
14
1367
13467
18
68
1295
12684
Pain localized to upper abdomen
R10.1 [45568111]
8.7e-01
5.2e-01
—
—
—
1.1e+00
8.1e-01
cases:1.79%
controls:0.76%
cases:0.50%
controls:0.30%
—
—
—
—
—
—
cases:1.02%
controls:0.33%
cases:2.21%
controls:1.00%
25
104
1368
13551
7
41
1386
13614
—
—
—
14
45
1362
13436
29
127
1284
12625
Exposure to other specified factors
X58 [45756411]
5.7e-01
2.1e+00
—
—
—
7.2e-01
7.1e-01
cases:1.65%
controls:0.94%
cases:1.79%
controls:0.23%
—
—
—
—
—
—
cases:0.65%
controls:0.32%
cases:2.44%
controls:1.22%
23
129
1370
13526
25
31
1368
13624
—
—
—
9
43
1367
13438
32
155
1281
12597
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
8.8e-01
1.7e+00
—
—
2.3e+00
1.3e+00
1.1e+00
cases:1.29%
controls:0.54%
cases:1.08%
controls:0.21%
—
—
—
—
cases:0.36%
controls:0.04%
cases:0.73%
controls:0.20%
cases:1.68%
controls:0.56%
18
74
1375
13581
15
28
1378
13627
—
—
5
5
1388
13639
10
27
1366
13454
22
72
1291
12680
European house dust mite IgE Ab [Units/volume] in Serum
6096-2 [3023351]
1.3e+00
2.8e+00
—
—
—
—
—
cases:0.65%
controls:0.17%
cases:0.57%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
9
23
1384
13632
8
5
1385
13650
—
—
—
—
—
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
6.7e-01
6.4e-01
—
—
—
8.3e-01
6.2e-01
cases:7.11%
controls:3.78%
cases:2.44%
controls:1.30%
—
—
—
—
—
—
cases:2.83%
controls:1.26%
cases:8.45%
controls:4.73%
99
516
1294
13139
34
178
1359
13477
—
—
—
39
170
1337
13311
111
603
1202
12149
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
6.7e-01
6.4e-01
—
—
—
8.3e-01
6.2e-01
cases:7.11%
controls:3.78%
cases:2.44%
controls:1.30%
—
—
—
—
—
—
cases:2.83%
controls:1.26%
cases:8.45%
controls:4.73%
99
516
1294
13139
34
178
1359
13477
—
—
—
39
170
1337
13311
111
603
1202
12149
Physiologic investigation of micturition
XKD06 [2001306098]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.04%
—
—
—
—
—
—
8
5
1305
12747
Removal of osteosynthesis material
9165 [2000101445]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.05%
—
—
—
—
—
—
11
7
1302
12745
Laboratory Visit
OMOP4822461 [32036]
1.9e-02
1.3e-01
5.0e-01
1.9e+00
1.9e-01
2.7e-01
7.5e-02
cases:16.08%
controls:15.83%
cases:16.44%
controls:14.72%
cases:6.68%
controls:4.15%
cases:1.29%
controls:0.19%
cases:4.95%
controls:4.13%
cases:18.97%
controls:15.19%
cases:28.03%
controls:26.54%
224
2161
1169
11494
229
2010
1164
11645
93
567
1300
13088
18
26
1375
13629
69
564
1324
13080
261
2048
1115
11433
368
3384
945
9368
Chronic alcohol abuse
P15 [2002000811]
1.4e+00
1.7e+00
—
—
—
—
1.3e+00
cases:0.72%
controls:0.18%
cases:0.36%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.27%
10
25
1383
13630
5
9
1388
13646
—
—
—
—
13
35
1300
12717
Other and unspecified abdominal pain
R10.4 [45568113]
9.6e-01
6.1e-01
6.0e-01
—
—
9.7e-01
7.1e-01
cases:6.32%
controls:2.51%
cases:1.44%
controls:0.78%
cases:0.36%
controls:0.20%
—
—
—
—
cases:2.11%
controls:0.81%
cases:6.70%
controls:3.42%
88
343
1305
13312
20
107
1373
13548
5
27
1388
13628
—
—
29
109
1347
13372
88
436
1225
12316
tizanidine; oral
M03BX02 [21604116]
6.1e-01
6.0e-01
8.6e-02
—
8.5e-01
8.2e-01
6.1e-01
cases:15.43%
controls:9.06%
cases:5.74%
controls:3.22%
cases:0.43%
controls:0.40%
—
—
cases:1.01%
controls:0.43%
cases:6.83%
controls:3.12%
cases:18.28%
controls:10.88%
215
1237
1178
12418
80
440
1313
13215
6
54
1387
13601
—
14
59
1379
13585
94
421
1282
13060
240
1387
1073
11365
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
6.8e-01
1.3e+00
1.8e+00
—
—
6.4e-01
6.5e-01
cases:3.30%
controls:1.70%
cases:2.15%
controls:0.59%
cases:0.43%
controls:0.07%
—
—
—
—
cases:1.09%
controls:0.58%
cases:4.57%
controls:2.44%
46
232
1347
13423
30
81
1363
13574
6
10
1387
13645
—
—
15
78
1361
13403
60
311
1253
12441
Mugwort IgE Ab [Units/volume] in Serum
6183-8 [3008401]
1.5e+00
2.6e+00
—
—
—
—
—
cases:0.50%
controls:0.12%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
7
16
1386
13639
7
5
1386
13650
—
—
—
—
—
Timothy IgE Ab [Units/volume] in Serum
6265-3 [3003888]
1.5e+00
2.6e+00
—
—
—
—
—
cases:0.50%
controls:0.12%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
7
16
1386
13639
7
5
1386
13650
—
—
—
—
—
Urethral pressure profilometry
XKD03 [2001306097]
1.8e+00
—
—
—
—
—
2.6e+00
cases:0.36%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.04%
5
8
1388
13647
—
—
—
—
—
7
5
1306
12747
Trigeminal neuralgia
G50.0 [45581502]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.04%
—
—
—
—
—
—
7
5
1306
12747
Uvulopalatopharyngoplasty
ENC40 [2001302321]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.04%
—
—
—
—
—
—
7
5
1306
12747
amitriptyline; oral, parenteral
N06AA09 [21604696]
5.8e-01
6.6e-01
8.6e-01
—
6.4e-01
9.8e-01
1.0e+00
cases:3.45%
controls:1.96%
cases:2.01%
controls:1.05%
cases:0.43%
controls:0.18%
—
—
cases:0.43%
controls:0.23%
cases:2.47%
controls:0.94%
cases:6.02%
controls:2.24%
48
267
1345
13388
28
143
1365
13512
6
25
1387
13630
—
6
31
1387
13613
34
127
1342
13354
79
286
1234
12466
No disease
A97 [2002000230]
6.4e-01
1.3e+00
—
—
—
1.3e+00
6.1e-01
cases:1.58%
controls:0.84%
cases:0.93%
controls:0.26%
—
—
—
—
—
—
cases:1.02%
controls:0.29%
cases:2.51%
controls:1.39%
22
115
1371
13540
13
35
1380
13620
—
—
—
14
39
1362
13442
33
177
1280
12575
formoterol and beclometasone
R03AK08 [43534839]
1.3e+00
1.3e+00
—
—
—
8.0e-01
1.2e+00
cases:0.79%
controls:0.21%
cases:0.65%
controls:0.18%
—
—
—
—
—
—
cases:0.51%
controls:0.23%
cases:1.07%
controls:0.32%
11
29
1382
13626
9
24
1384
13631
—
—
—
7
31
1369
13450
14
41
1299
12711
ebastine; oral
R06AX22 [21603521]
8.2e-01
9.1e-01
—
—
—
7.6e-01
7.9e-01
cases:3.23%
controls:1.45%
cases:1.79%
controls:0.73%
—
—
—
—
—
—
cases:1.45%
controls:0.68%
cases:3.66%
controls:1.69%
45
198
1348
13457
25
100
1368
13555
—
—
—
20
92
1356
13389
48
216
1265
12536
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
2.8e-01
8.2e-01
1.5e+00
—
1.3e+00
1.1e+00
5.6e-01
cases:2.15%
controls:1.64%
cases:1.51%
controls:0.67%
cases:0.36%
controls:0.08%
—
—
cases:0.36%
controls:0.10%
cases:1.74%
controls:0.58%
cases:3.50%
controls:2.02%
30
224
1363
13431
21
91
1372
13564
5
11
1388
13644
—
5
14
1388
13630
24
78
1352
13403
46
258
1267
12494
Examination of ears and hearing
Z01.1 [45547279]
6.8e-01
1.4e+00
—
—
—
1.1e+00
1.1e+00
cases:1.22%
controls:0.62%
cases:0.93%
controls:0.23%
—
—
—
—
—
—
cases:0.51%
controls:0.16%
cases:1.90%
controls:0.66%
17
85
1376
13570
13
31
1380
13624
—
—
—
7
22
1369
13459
25
84
1288
12668
salbutamol; inhalant
R03AC02 [21603256]
5.5e-01
6.0e-01
5.3e-01
—
9.2e-01
7.2e-01
6.2e-01
cases:12.06%
controls:7.32%
cases:6.25%
controls:3.53%
cases:1.01%
controls:0.59%
—
—
cases:1.22%
controls:0.49%
cases:6.76%
controls:3.42%
cases:15.46%
controls:8.92%
168
1000
1225
12655
87
482
1306
13173
14
81
1379
13574
—
17
67
1376
13577
93
461
1283
13020
203
1137
1110
11615
triamcinolone; nasal
R01AD11 [21605052]
7.6e-01
1.4e+00
—
—
—
4.5e-01
1.1e+00
cases:1.44%
controls:0.67%
cases:1.08%
controls:0.26%
—
—
—
—
—
—
cases:0.51%
controls:0.33%
cases:1.52%
controls:0.53%
20
92
1373
13563
15
36
1378
13619
—
—
—
7
44
1369
13437
20
67
1293
12685
Dentistry
C5 [903277]
6.3e-01
1.2e+00
—
—
—
8.6e-01
6.7e-01
cases:2.80%
controls:1.51%
cases:1.65%
controls:0.51%
—
—
—
—
—
—
cases:1.24%
controls:0.53%
cases:2.82%
controls:1.46%
39
206
1354
13449
23
70
1370
13585
—
—
—
17
71
1359
13410
37
186
1276
12566
calcium (different salts in combination); oral
A12AA20 [21600872]
6.2e-01
7.0e-01
2.2e-01
—
9.4e-01
6.7e-01
4.8e-01
cases:5.24%
controls:2.90%
cases:4.09%
controls:2.08%
cases:0.57%
controls:0.46%
—
—
cases:1.08%
controls:0.43%
cases:4.36%
controls:2.28%
cases:6.25%
controls:3.94%
73
396
1320
13259
57
284
1336
13371
8
63
1385
13592
—
15
58
1378
13586
60
307
1316
13174
82
503
1231
12249
Inhalation anesthesia
WX400 [2001310805]
4.1e-01
—
—
—
—
2.5e+00
1.2e+00
cases:0.43%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.04%
cases:0.76%
controls:0.23%
6
39
1387
13616
—
—
—
—
6
5
1370
13476
10
29
1303
12723
Nonallergic asthma
J45.1 [45557625]
4.6e-01
1.4e+00
—
—
—
1.2e+00
1.1e+00
cases:0.72%
controls:0.45%
cases:0.72%
controls:0.18%
—
—
—
—
—
—
cases:0.58%
controls:0.18%
cases:1.60%
controls:0.54%
10
62
1383
13593
10
25
1383
13630
—
—
—
8
24
1368
13457
21
69
1292
12683
clidinium and psycholeptics
A03CA02 [21600204]
8.3e-01
1.4e+00
—
—
—
9.0e-01
1.1e+00
cases:1.01%
controls:0.44%
cases:0.72%
controls:0.18%
—
—
—
—
—
—
cases:0.51%
controls:0.21%
cases:1.45%
controls:0.51%
14
60
1379
13595
10
24
1383
13631
—
—
—
7
28
1369
13453
19
65
1294
12687
Arthroplasty of interphalangeal tarsal joint(s)
NHG77 [2001308321]
1.3e+00
—
—
—
—
—
2.5e+00
cases:0.36%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.04%
5
13
1388
13642
—
—
—
—
—
6
5
1307
12747
Open wound of nose
S01.2 [45553788]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.04%
—
—
—
—
—
—
6
5
1307
12747
Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11259-9 [3021125]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.04%
—
—
—
—
—
—
6
5
1307
12747
Shortness of breath/dyspnoea
R02 [2002000883]
7.6e-01
1.5e+00
—
—
—
1.1e+00
9.5e-01
cases:0.93%
controls:0.44%
cases:0.72%
controls:0.16%
—
—
—
—
—
—
cases:0.51%
controls:0.17%
cases:1.75%
controls:0.68%
13
60
1380
13595
10
22
1383
13633
—
—
—
7
23
1369
13458
23
87
1290
12665
General symptom/complaint other
A29 [2002000163]
7.5e-01
8.6e-01
—
—
—
1.4e+00
1.1e+00
cases:0.79%
controls:0.37%
cases:0.43%
controls:0.18%
—
—
—
—
—
—
cases:0.80%
controls:0.20%
cases:2.21%
controls:0.78%
11
51
1382
13604
6
25
1387
13630
—
—
—
11
27
1365
13454
29
99
1284
12653
Removal of internal fixation device from ankle or foot
NHU20 [2001308384]
6.8e-01
—
—
—
—
2.4e+00
1.2e+00
cases:0.43%
controls:0.22%
—
—
—
—
—
—
—
—
cases:0.51%
controls:0.04%
cases:0.76%
controls:0.23%
6
30
1387
13625
—
—
—
—
7
6
1369
13475
10
29
1303
12723
Cervical spine X-ray examination with flexion
NA1EA [2001307001]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.05%
—
—
—
—
—
—
7
6
1306
12746
Chest pain, unspecified
R07.4 [45558450]
7.2e-01
9.4e-01
—
—
—
7.4e-01
7.5e-01
cases:3.52%
controls:1.75%
cases:1.44%
controls:0.56%
—
—
—
—
—
—
cases:1.02%
controls:0.49%
cases:4.57%
controls:2.20%
49
239
1344
13416
20
77
1373
13578
—
—
—
14
66
1362
13415
60
281
1253
12471
Office Visit
OMOP4822458 [581477]
5.6e-01
6.0e-01
5.5e-01
—
6.3e-01
8.0e-01
4.4e-01
cases:8.54%
controls:5.05%
cases:3.16%
controls:1.75%
cases:0.43%
controls:0.25%
—
—
cases:0.57%
controls:0.31%
cases:3.34%
controls:1.54%
cases:7.84%
controls:5.18%
119
689
1274
12966
44
239
1349
13416
6
34
1387
13621
—
8
42
1385
13602
46
207
1330
13274
103
660
1210
12092
Other and unspecified convulsions
R56.8 [45602033]
1.3e+00
—
—
—
—
—
1.2e+00
cases:1.22%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.31%
17
48
1376
13607
—
—
—
—
—
13
40
1300
12712
Neurology
13 [38004458]
5.3e-01
7.3e-01
2.9e-01
—
8.9e-01
6.4e-01
5.1e-01
cases:8.61%
controls:5.27%
cases:4.45%
controls:2.20%
cases:0.57%
controls:0.43%
—
—
cases:1.15%
controls:0.48%
cases:4.00%
controls:2.15%
cases:10.05%
controls:6.29%
120
719
1273
12936
62
300
1331
13355
8
59
1385
13596
—
16
65
1377
13579
55
290
1321
13191
132
802
1181
11950
Other chronic pain
R52.2 [45568139]
—
2.4e+00
—
—
—
—
—
—
—
cases:0.65%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
9
8
1384
13647
—
—
—
—
—
Pain in limb
M79.6 [45587063]
6.3e-01
1.1e+00
—
—
-1.0e+50
6.4e-01
7.0e-01
cases:4.09%
controls:2.21%
cases:2.37%
controls:0.83%
—
—
—
—
cases:0.00%
controls:0.10%
cases:2.03%
controls:1.08%
cases:7.39%
controls:3.80%
57
302
1336
13353
33
114
1360
13541
—
—
0
14
1393
13630
28
146
1348
13335
97
484
1216
12268
dexchlorpheniramine, combinations
R06AB52 [21603467]
1.0e+00
1.4e+00
—
—
—
—
-1.8e-02
cases:1.36%
controls:0.49%
cases:0.79%
controls:0.21%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.70%
19
67
1374
13588
11
28
1382
13627
—
—
—
—
9
89
1304
12663
glucosamine; oral
M01AX05 [21604002]
7.1e-01
1.0e+00
1.7e+00
—
—
7.7e-01
6.6e-01
cases:3.09%
controls:1.54%
cases:1.65%
controls:0.61%
cases:0.36%
controls:0.07%
—
—
—
—
cases:1.31%
controls:0.61%
cases:3.35%
controls:1.76%
43
210
1350
13445
23
83
1370
13572
5
9
1388
13646
—
—
18
82
1358
13399
44
224
1269
12528
Monitoring vital functions without anesthesia
WX000 [2001310756]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.11%
—
—
—
—
—
—
15
14
1298
12738
Microorganisms panel - Urine sediment
58435-9 [40761536]
7.8e-01
1.4e+00
—
—
-1.0e+50
1.1e+00
9.6e-01
cases:1.15%
controls:0.53%
cases:0.79%
controls:0.20%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.65%
controls:0.22%
cases:1.68%
controls:0.65%
16
72
1377
13583
11
27
1382
13628
—
—
0
5
1393
13639
9
30
1367
13451
22
83
1291
12669
azithromycin; oral, parenteral
J01FA10 [21602978]
4.1e-01
7.6e-01
—
—
3.4e-01
6.6e-01
4.8e-01
cases:11.13%
controls:7.67%
cases:4.38%
controls:2.09%
—
—
—
—
cases:0.36%
controls:0.26%
cases:4.29%
controls:2.26%
cases:12.49%
controls:8.09%
155
1047
1238
12608
61
286
1332
13369
—
—
5
35
1388
13609
59
304
1317
13177
164
1032
1149
11720
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
6.0e-01
1.4e+00
—
—
—
8.4e-01
9.2e-01
cases:0.93%
controls:0.51%
cases:0.72%
controls:0.18%
—
—
—
—
—
—
cases:0.58%
controls:0.25%
cases:1.60%
controls:0.64%
13
70
1380
13585
10
25
1383
13630
—
—
—
8
34
1368
13447
21
82
1292
12670
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
8.0e-01
2.3e+00
—
—
—
—
8.9e-01
cases:0.72%
controls:0.32%
cases:0.65%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.41%
10
44
1383
13611
9
9
1384
13646
—
—
—
—
13
52
1300
12700
Campylobacter sp identified in Tissue by Organism specific culture
20740-7 [3006418]
—
—
—
—
—
2.3e+00
1.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.04%
cases:0.53%
controls:0.20%
—
—
—
—
—
6
6
1370
13475
7
25
1306
12727
Yersinia sp identified in Stool by Organism specific culture
28549-4 [3014765]
—
—
—
—
—
2.3e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.04%
cases:0.61%
controls:0.20%
—
—
—
—
—
6
6
1370
13475
8
25
1305
12727
Shigella sp [Presence] in Stool by Culture
82300-5 [42529406]
—
—
—
—
—
2.3e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.04%
cases:0.61%
controls:0.20%
—
—
—
—
—
6
6
1370
13475
8
25
1305
12727
Scar conditions and fibrosis of skin
L90.5 [45543397]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.06%
—
—
—
—
—
—
8
8
1305
12744
Repair/fix-suture/cast/prosth device
-54 [2002000125]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.05%
—
—
—
—
—
—
7
7
1306
12745
Other rheumatoid arthritis
M06 [45596441]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.05%
—
—
—
—
—
—
6
6
1307
12746
alprazolam; oral
N05BA12 [21604577]
6.7e-01
8.4e-01
1.1e+00
—
9.9e-01
1.2e+00
1.1e+00
cases:1.87%
controls:0.97%
cases:1.15%
controls:0.50%
cases:0.43%
controls:0.14%
—
—
cases:0.43%
controls:0.16%
cases:1.60%
controls:0.47%
cases:2.97%
controls:1.06%
26
132
1367
13523
16
68
1377
13587
6
19
1387
13636
—
6
22
1387
13622
22
64
1354
13417
39
135
1274
12617
desloratadine; oral
R06AX27 [21603526]
6.6e-01
9.7e-01
—
—
9.3e-01
6.1e-01
6.3e-01
cases:5.10%
controls:2.71%
cases:3.45%
controls:1.33%
—
—
—
—
cases:0.50%
controls:0.20%
cases:2.62%
controls:1.44%
cases:6.47%
controls:3.55%
71
370
1322
13285
48
182
1345
13473
—
—
7
27
1386
13617
36
194
1340
13287
85
453
1228
12299
Internal hemorrhoids without complication
I84.2 [45596267]
1.2e+00
—
—
—
—
—
1.1e+00
cases:1.15%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.33%
16
50
1377
13605
—
—
—
—
—
13
42
1300
12710
Concussion
S06.0 [45582805]
1.2e+00
1.3e+00
—
—
—
1.3e+00
1.1e+00
cases:1.72%
controls:0.53%
cases:0.72%
controls:0.20%
—
—
—
—
—
—
cases:0.51%
controls:0.13%
cases:1.75%
controls:0.61%
24
73
1369
13582
10
27
1383
13628
—
—
—
7
18
1369
13463
23
78
1290
12674
antibiotics in combination with corticosteroids
D01AA20 [21601918]
5.3e-01
3.6e-01
—
—
—
1.5e+00
7.6e-01
cases:1.87%
controls:1.11%
cases:0.50%
controls:0.35%
—
—
—
—
—
—
cases:0.80%
controls:0.19%
cases:2.28%
controls:1.08%
26
151
1367
13504
7
48
1386
13607
—
—
—
11
25
1365
13456
30
138
1283
12614
Intraoral radiographic dental examination
EB1AA [2001301903]
4.5e-01
6.7e-01
—
—
7.0e-01
6.0e-01
5.1e-01
cases:8.33%
controls:5.49%
cases:4.31%
controls:2.26%
—
—
—
—
cases:0.50%
controls:0.25%
cases:3.92%
controls:2.19%
cases:12.72%
controls:8.05%
116
750
1277
12905
60
308
1333
13347
—
—
7
34
1386
13610
54
295
1322
13186
167
1027
1146
11725
piroxicam; oral, parenteral, rectal
M01AC01 [21603961]
4.1e-01
8.9e-01
1.2e+00
—
—
6.9e-01
6.4e-01
cases:5.46%
controls:3.70%
cases:2.15%
controls:0.89%
cases:0.43%
controls:0.12%
—
—
—
—
cases:2.11%
controls:1.07%
cases:7.16%
controls:3.90%
76
505
1317
13150
30
122
1363
13533
6
17
1387
13638
—
—
29
144
1347
13337
94
497
1219
12255
Cystoscopy
UKC02 [2001306005]
1.2e+00
—
—
—
—
—
1.0e+00
cases:1.94%
controls:0.61%
—
—
—
—
—
—
—
—
—
—
cases:2.36%
controls:0.84%
27
83
1366
13572
—
—
—
—
—
31
107
1282
12645
Treatment of a patient needing special arrangements
WYA30 [2001310874]
1.2e+00
1.2e+00
—
—
—
9.8e-01
1.1e+00
cases:1.58%
controls:0.51%
cases:0.65%
controls:0.19%
—
—
—
—
—
—
cases:0.73%
controls:0.27%
cases:1.45%
controls:0.50%
22
69
1371
13586
9
26
1384
13629
—
—
—
10
37
1366
13444
19
64
1294
12688
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
1.2e+00
—
—
—
—
—
1.0e+00
cases:0.93%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.42%
13
39
1380
13616
—
—
—
—
—
15
53
1298
12699
Sinoscopy
UDM02 [2001301774]
1.2e+00
—
—
—
—
—
2.2e+00
cases:0.43%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.11%
6
18
1387
13637
—
—
—
—
—
13
14
1300
12738
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
9.6e-01
1.1e+00
—
—
—
—
1.2e+00
cases:1.22%
controls:0.47%
cases:0.50%
controls:0.18%
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.42%
17
64
1376
13591
7
24
1386
13631
—
—
—
—
19
54
1294
12698
imidazoles/triazoles in combination with corticosteroids
D01AC20 [21601936]
5.3e-01
4.2e-01
1.3e+00
—
—
9.5e-01
7.2e-01
cases:4.31%
controls:2.57%
cases:1.44%
controls:0.94%
cases:0.36%
controls:0.10%
—
—
—
—
cases:1.82%
controls:0.71%
cases:5.56%
controls:2.78%
60
351
1333
13304
20
129
1373
13526
5
14
1388
13641
—
—
25
96
1351
13385
73
355
1240
12397
quetiapine; oral
N05AH04 [21604544]
6.2e-01
7.9e-01
8.0e-01
—
9.9e-01
5.4e-01
7.9e-01
cases:3.09%
controls:1.68%
cases:2.44%
controls:1.13%
cases:0.72%
controls:0.32%
—
—
cases:0.86%
controls:0.32%
cases:1.96%
controls:1.15%
cases:4.72%
controls:2.20%
43
230
1350
13425
34
154
1359
13501
10
44
1383
13611
—
12
44
1381
13600
27
155
1349
13326
62
281
1251
12471
Overweight
T83 [2002001126]
—
—
—
—
—
-1.0e+50
2.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.76%
controls:0.09%
—
—
—
—
—
0
5
1376
13476
10
11
1303
12741
cromoglicic acid
S01GX01 [21605085]
3.4e-01
8.2e-01
—
—
—
8.2e-01
5.5e-01
cases:2.80%
controls:2.01%
cases:1.72%
controls:0.77%
—
—
—
—
—
—
cases:1.60%
controls:0.71%
cases:3.58%
controls:2.10%
39
274
1354
13381
24
105
1369
13550
—
—
—
22
96
1354
13385
47
268
1266
12484
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
1.3e+00
1.3e+00
—
—
—
9.5e-01
8.6e-01
cases:2.01%
controls:0.55%
cases:0.79%
controls:0.23%
—
—
—
—
—
—
cases:0.36%
controls:0.14%
cases:1.98%
controls:0.85%
28
75
1365
13580
11
31
1382
13624
—
—
—
5
19
1371
13462
26
108
1287
12644
nystatin; oral
A07AA02 [21600604]
4.9e-01
—
—
—
—
2.2e+00
7.6e-01
cases:0.65%
controls:0.40%
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.07%
cases:0.91%
controls:0.43%
9
54
1384
13601
—
—
—
—
8
9
1368
13472
12
55
1301
12697
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.5e+00
2.3e+00
—
—
—
2.2e+00
1.5e+00
cases:0.57%
controls:0.13%
cases:0.36%
controls:0.04%
—
—
—
—
—
—
cases:0.51%
controls:0.06%
cases:0.53%
controls:0.13%
8
18
1385
13637
5
5
1388
13650
—
—
—
7
8
1369
13473
7
16
1306
12736
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
9.9e-01
—
—
—
—
2.2e+00
8.2e-01
cases:0.43%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.51%
controls:0.06%
cases:0.53%
controls:0.24%
6
22
1387
13633
—
—
—
—
7
8
1369
13473
7
30
1306
12722
omeprazole; oral, parenteral
A02BC01 [21600096]
7.0e-01
6.2e-01
1.5e+00
—
7.0e-01
7.7e-01
6.9e-01
cases:4.88%
controls:2.49%
cases:1.94%
controls:1.05%
cases:0.50%
controls:0.11%
—
—
cases:0.50%
controls:0.25%
cases:2.25%
controls:1.06%
cases:5.94%
controls:3.08%
68
340
1325
13315
27
144
1366
13511
7
15
1386
13640
—
7
34
1386
13610
31
143
1345
13338
78
393
1235
12359
Allergic rhinitis due to pollen
J30.10 [2000502594]
6.4e-01
1.2e+00
—
—
—
2.1e+00
4.8e-01
cases:0.72%
controls:0.38%
cases:0.43%
controls:0.12%
—
—
—
—
—
—
cases:0.94%
controls:0.11%
cases:0.69%
controls:0.42%
10
52
1383
13603
6
17
1387
13638
—
—
—
13
15
1363
13466
9
54
1304
12698
Encounter/prob initiated by provider
-64 [2002000135]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.06%
—
—
—
—
—
—
7
8
1306
12744
Arthroscopy and meniscus surgery
1221 [2000100103]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.06%
—
—
—
—
—
—
7
8
1306
12744
Basocellular carcinoma of the skin on another or unspecified part of the face
C44.31 [2000500792]
9.4e-01
2.1e+00
—
—
—
1.5e+00
8.1e-01
cases:0.50%
controls:0.20%
cases:0.86%
controls:0.10%
—
—
—
—
—
—
cases:0.51%
controls:0.11%
cases:0.46%
controls:0.20%
7
27
1386
13628
12
14
1381
13641
—
—
—
7
15
1369
13466
6
26
1307
12726
Polyp of nasal cavity
J33.0 [45562447]
1.7e+00
2.1e+00
—
—
—
—
7.7e-01
cases:0.50%
controls:0.09%
cases:0.43%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.28%
7
12
1386
13643
6
7
1387
13648
—
—
—
—
8
36
1305
12716
Neck ultrasound examination
EP1AE [2001302284]
5.5e-01
2.1e+00
—
—
—
-1.0e+50
—
cases:0.43%
controls:0.25%
cases:0.43%
controls:0.05%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
6
34
1387
13621
6
7
1387
13648
—
—
—
0
8
1376
13473
—
Seronegative rheumatoid arthritis
M06.0 [45577103]
1.5e+00
2.1e+00
—
—
—
1.6e+00
1.4e+00
cases:0.36%
controls:0.08%
cases:0.43%
controls:0.05%
—
—
—
—
—
—
cases:0.44%
controls:0.09%
cases:0.69%
controls:0.16%
5
11
1388
13644
6
7
1387
13648
—
—
—
6
12
1370
13469
9
21
1304
12731
Measurement of mechanical axis of lower leg with X-ray
NJ2MA [2001308419]
7.1e-01
—
—
—
—
2.1e+00
1.1e+00
cases:0.43%
controls:0.21%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.05%
cases:0.69%
controls:0.22%
6
29
1387
13626
—
—
—
—
6
7
1370
13474
9
28
1304
12724
tamsulosin; oral
G04CA02 [21602669]
6.5e-01
6.9e-01
5.6e-01
—
3.7e-01
9.0e-01
5.7e-01
cases:2.66%
controls:1.40%
cases:1.79%
controls:0.91%
cases:0.36%
controls:0.21%
—
—
cases:0.36%
controls:0.25%
cases:2.18%
controls:0.90%
cases:3.73%
controls:2.15%
37
191
1356
13464
25
124
1368
13531
5
28
1388
13627
—
5
34
1388
13610
30
121
1346
13360
49
274
1264
12478
Ultrasound examination of groin and abdominal wall
JA1AE [2001304364]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.05%
—
—
—
—
—
—
6
7
1307
12745
Other primary coxarthrosis
M16.1 [45591741]
1.2e+00
1.4e+00
—
—
—
1.3e+00
9.2e-01
cases:1.08%
controls:0.33%
cases:0.57%
controls:0.14%
—
—
—
—
—
—
cases:0.65%
controls:0.18%
cases:1.60%
controls:0.64%
15
45
1378
13610
8
19
1385
13636
—
—
—
9
24
1367
13457
21
82
1292
12670
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
4.8e-01
1.3e+00
—
—
-1.0e+50
1.3e+00
8.3e-01
cases:0.79%
controls:0.49%
cases:0.50%
controls:0.14%
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.80%
controls:0.22%
cases:1.60%
controls:0.71%
11
67
1382
13588
7
19
1386
13636
—
—
0
7
1393
13637
11
30
1365
13451
21
90
1292
12662
Other specified intervertebral disc degeneration
M51.3 [45591865]
1.2e+00
1.2e+00
—
—
—
1.0e+00
9.2e-01
cases:1.29%
controls:0.40%
cases:0.65%
controls:0.19%
—
—
—
—
—
—
cases:0.44%
controls:0.16%
cases:1.37%
controls:0.55%
18
55
1375
13600
9
26
1384
13629
—
—
—
6
21
1370
13460
18
70
1295
12682
Reparation of dental prosthesis without impressions
SPF00 [2001310544]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.09%
—
—
—
—
—
—
9
11
1304
12741
Back syndrome without radiat pain
L84 [2002000703]
1.0e+00
—
—
—
—
—
2.1e+00
cases:0.43%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.13%
6
21
1387
13634
—
—
—
—
—
13
16
1300
12736
meloxicam; oral, parenteral, rectal
M01AC06 [21603965]
6.0e-01
8.4e-01
—
—
1.4e+00
6.9e-01
6.3e-01
cases:5.17%
controls:2.91%
cases:2.01%
controls:0.88%
—
—
—
—
cases:0.43%
controls:0.10%
cases:1.89%
controls:0.96%
cases:6.40%
controls:3.53%
72
398
1321
13257
28
120
1365
13535
—
—
6
14
1387
13630
26
129
1350
13352
84
450
1229
12302
Persistent somatoform pain disorder
F45.4 [45605498]
1.9e+00
—
—
—
—
—
2.1e+00
cases:0.43%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.08%
6
9
1387
13646
—
—
—
—
—
8
10
1305
12742
General medical examination
Z00.0 [45585791]
5.7e-01
2.0e-01
-1.0e+50
—
—
1.2e+00
8.4e-01
cases:2.08%
controls:1.19%
cases:0.50%
controls:0.41%
cases:0.00%
controls:0.06%
—
—
—
—
cases:1.09%
controls:0.33%
cases:2.74%
controls:1.21%
29
163
1364
13492
7
56
1386
13599
0
8
1393
13647
—
—
15
44
1361
13437
36
154
1277
12598
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
6.3e-01
2.0e+00
—
—
—
—
4.8e-01
cases:0.86%
controls:0.46%
cases:0.79%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.52%
12
63
1381
13592
11
14
1382
13641
—
—
—
—
11
66
1302
12686
sodium picosulfate; oral
A06AB08 [21600545]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.07%
—
—
—
—
—
—
7
9
1306
12743
General and Unspecified, Other reason for encounter NEC
A69 [2002000203]
—
—
—
—
—
-1.0e+50
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.76%
controls:0.10%
—
—
—
—
—
0
5
1376
13476
10
13
1303
12739
hydrocortisone
A07EA02 [21600654]
6.6e-01
5.5e-01
1.1e+00
—
—
8.2e-01
5.4e-01
cases:8.83%
controls:4.77%
cases:2.73%
controls:1.60%
cases:0.50%
controls:0.17%
—
—
—
—
cases:3.49%
controls:1.57%
cases:9.06%
controls:5.50%
123
652
1270
13003
38
218
1355
13437
7
23
1386
13632
—
—
48
212
1328
13269
119
701
1194
12051
hydrocortisone
C05AA01 [21601608]
6.6e-01
5.5e-01
1.1e+00
—
—
8.2e-01
5.4e-01
cases:8.83%
controls:4.77%
cases:2.73%
controls:1.60%
cases:0.50%
controls:0.17%
—
—
—
—
cases:3.49%
controls:1.57%
cases:9.06%
controls:5.50%
123
652
1270
13003
38
218
1355
13437
7
23
1386
13632
—
—
48
212
1328
13269
119
701
1194
12051
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.8e-01
5.7e-01
7.7e-01
—
2.3e-01
6.4e-01
4.1e-01
cases:8.40%
controls:5.90%
cases:5.03%
controls:2.91%
cases:0.79%
controls:0.37%
—
—
cases:0.65%
controls:0.51%
cases:5.38%
controls:2.90%
cases:13.10%
controls:9.06%
117
806
1276
12849
70
398
1323
13257
11
50
1382
13605
—
9
70
1384
13574
74
391
1302
13090
172
1155
1141
11597
pseudoephedrine, combinations; oral
R01BA52 [21603213]
3.4e-01
7.2e-01
7.7e-01
—
5.6e-01
5.0e-01
4.4e-01
cases:10.34%
controls:7.56%
cases:5.03%
controls:2.50%
cases:0.65%
controls:0.30%
—
—
cases:0.36%
controls:0.21%
cases:4.22%
controls:2.60%
cases:12.19%
controls:8.20%
144
1033
1249
12622
70
342
1323
13313
9
41
1384
13614
—
5
28
1388
13616
58
351
1318
13130
160
1046
1153
11706
Alcohol dependence continuous use
F10.25 [2000501682]
2.0e+00
—
—
—
—
—
1.5e+00
cases:0.65%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.13%
9
12
1384
13643
—
—
—
—
—
7
16
1306
12736
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
6.6e-01
7.8e-01
—
—
—
1.2e+00
8.0e-01
cases:2.08%
controls:1.08%
cases:1.01%
controls:0.46%
—
—
—
—
—
—
cases:1.16%
controls:0.36%
cases:2.82%
controls:1.29%
29
148
1364
13507
14
63
1379
13592
—
—
—
16
48
1360
13433
37
164
1276
12588
Mixed personality disorders
F61.0 [2000502024]
—
-1.0e+50
—
—
—
—
2.0e+00
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.09%
—
0
11
1393
13644
—
—
—
—
9
12
1304
12740
hydrocortisone buteprate
D07AB11 [21602115]
6.8e-01
5.6e-01
1.1e+00
—
—
7.6e-01
5.5e-01
cases:8.76%
controls:4.65%
cases:2.73%
controls:1.58%
cases:0.50%
controls:0.16%
—
—
—
—
cases:3.27%
controls:1.55%
cases:8.91%
controls:5.35%
122
635
1271
13020
38
216
1355
13439
7
22
1386
13633
—
—
45
209
1331
13272
117
682
1196
12070
hydrocortisone
D07AA02 [21602102]
6.8e-01
5.6e-01
1.1e+00
—
—
7.6e-01
5.5e-01
cases:8.76%
controls:4.65%
cases:2.73%
controls:1.58%
cases:0.50%
controls:0.16%
—
—
—
—
cases:3.27%
controls:1.55%
cases:8.91%
controls:5.35%
122
635
1271
13020
38
216
1355
13439
7
22
1386
13633
—
—
45
209
1331
13272
117
682
1196
12070
hydrocortisone aceponate
D07AC16 [21602135]
6.8e-01
5.6e-01
1.1e+00
—
—
7.6e-01
5.5e-01
cases:8.76%
controls:4.65%
cases:2.73%
controls:1.58%
cases:0.50%
controls:0.16%
—
—
—
—
cases:3.27%
controls:1.55%
cases:8.91%
controls:5.35%
122
635
1271
13020
38
216
1355
13439
7
22
1386
13633
—
—
45
209
1331
13272
117
682
1196
12070
hydrocortisone butyrate
D07AB02 [21602106]
6.8e-01
5.6e-01
1.1e+00
—
—
7.6e-01
5.5e-01
cases:8.76%
controls:4.65%
cases:2.73%
controls:1.58%
cases:0.50%
controls:0.16%
—
—
—
—
cases:3.27%
controls:1.55%
cases:8.91%
controls:5.35%
122
635
1271
13020
38
216
1355
13439
7
22
1386
13633
—
—
45
209
1331
13272
117
682
1196
12070
Normoblasts [#/volume] in Blood
715-3 [3021589]
2.6e-01
5.3e-01
3.8e-01
—
2.2e-01
7.8e-01
6.8e-01
cases:3.80%
controls:2.96%
cases:3.59%
controls:2.15%
cases:0.93%
controls:0.64%
—
—
cases:0.72%
controls:0.58%
cases:4.72%
controls:2.22%
cases:8.91%
controls:4.74%
53
404
1340
13251
50
294
1343
13361
13
87
1380
13568
—
10
79
1383
13565
65
299
1311
13182
117
604
1196
12148
hydrocortisone and antiinfectives
S02CA03 [21605175]
7.4e-01
6.2e-01
—
—
-1.0e+50
1.2e+00
6.1e-01
cases:2.37%
controls:1.14%
cases:0.79%
controls:0.42%
—
—
—
—
cases:0.00%
controls:0.04%
cases:1.02%
controls:0.30%
cases:2.44%
controls:1.34%
33
156
1360
13499
11
58
1382
13597
—
—
0
5
1393
13639
14
40
1362
13441
32
171
1281
12581
hydrocortisone and antiinfectives
S03CA04 [21605208]
7.4e-01
6.2e-01
—
—
-1.0e+50
1.2e+00
6.1e-01
cases:2.37%
controls:1.14%
cases:0.79%
controls:0.42%
—
—
—
—
cases:0.00%
controls:0.04%
cases:1.02%
controls:0.30%
cases:2.44%
controls:1.34%
33
156
1360
13499
11
58
1382
13597
—
—
0
5
1393
13639
14
40
1362
13441
32
171
1281
12581
Bacteria identified in Stool by Culture
625-4 [3025941]
5.9e-01
1.5e+00
—
—
—
2.0e+00
5.0e-01
cases:0.79%
controls:0.44%
cases:0.36%
controls:0.08%
—
—
—
—
—
—
cases:0.58%
controls:0.08%
cases:0.76%
controls:0.46%
11
60
1382
13595
5
11
1388
13644
—
—
—
8
11
1368
13470
10
59
1303
12693
Dorsalgia, unspecified
M54.9 [45538791]
9.8e-01
9.5e-01
—
—
—
1.2e+00
9.8e-01
cases:1.44%
controls:0.54%
cases:0.36%
controls:0.14%
—
—
—
—
—
—
cases:0.58%
controls:0.18%
cases:2.13%
controls:0.81%
20
74
1373
13581
5
19
1388
13636
—
—
—
8
24
1368
13457
28
103
1285
12649
hydrocortisone
S02BA01 [21605166]
6.7e-01
4.4e-01
1.3e+00
—
—
7.6e-01
5.4e-01
cases:7.82%
controls:4.15%
cases:2.15%
controls:1.39%
cases:0.50%
controls:0.14%
—
—
—
—
cases:2.91%
controls:1.39%
cases:7.69%
controls:4.65%
109
566
1284
13089
30
190
1363
13465
7
19
1386
13636
—
—
40
187
1336
13294
101
593
1212
12159
Knee symptom/complaint
L15 [2002000639]
3.7e-01
4.7e-01
—
—
-1.0e+50
1.1e+00
9.1e-01
cases:1.51%
controls:1.05%
cases:0.65%
controls:0.40%
—
—
—
—
cases:0.00%
controls:0.05%
cases:1.16%
controls:0.41%
cases:3.66%
controls:1.51%
21
143
1372
13512
9
55
1384
13600
—
—
0
7
1393
13637
16
55
1360
13426
48
192
1265
12560
sulfasalazine; oral, rectal
A07EC01 [21600663]
7.8e-01
7.8e-01
—
—
—
1.1e+00
8.6e-01
cases:1.58%
controls:0.73%
cases:1.22%
controls:0.56%
—
—
—
—
—
—
cases:1.53%
controls:0.51%
cases:1.90%
controls:0.82%
22
100
1371
13555
17
77
1376
13578
—
—
—
21
69
1355
13412
25
104
1288
12648
Shoulder and humerus extensive MRI examination with high intensity magnet
NB1CG [2001307237]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.09%
—
—
—
—
—
—
8
11
1305
12741
Thoracal spine X-ray examination without contrast
NA2AA [2001307007]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.09%
—
—
—
—
—
—
8
11
1305
12741
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
4.7e-01
4.9e-01
-1.0e+50
—
—
1.2e+00
7.0e-01
cases:1.65%
controls:1.04%
cases:0.50%
controls:0.31%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.87%
controls:0.25%
cases:3.20%
controls:1.61%
23
142
1370
13513
7
42
1386
13613
0
6
1393
13649
—
—
12
34
1364
13447
42
205
1271
12547
CT angiography of head and neck vasculature
PA7AD [2001300233]
-1.0e+50
—
—
—
—
—
1.9e+00
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.11%
0
10
1393
13645
—
—
—
—
—
10
14
1303
12738
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
1.0e+00
—
—
—
—
—
1.9e+00
cases:0.57%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:1.29%
controls:0.19%
8
29
1385
13626
—
—
—
—
—
17
24
1296
12728
Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11268-0 [3000924]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.08%
—
—
—
—
—
—
7
10
1306
12742
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
281 [2001600213]
1.1e+00
—
—
—
—
—
1.9e+00
cases:0.36%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.10%
5
16
1388
13639
—
—
—
—
—
9
13
1304
12739
Supine thorax X-ray examination
GD1QA [2001303648]
1.1e+00
8.0e-01
—
—
—
—
7.6e-01
cases:1.36%
controls:0.44%
cases:0.36%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.90%
19
60
1374
13595
5
22
1388
13633
—
—
—
—
25
115
1288
12637
Upper gastrointestinal surgery
106 [44777669]
7.2e-01
3.4e-01
—
—
—
6.6e-01
5.1e-01
cases:7.54%
controls:3.80%
cases:1.94%
controls:1.38%
—
—
—
—
—
—
cases:2.83%
controls:1.48%
cases:7.84%
controls:4.89%
105
519
1288
13136
27
189
1366
13466
—
—
—
39
200
1337
13281
103
623
1210
12129
pseudoephedrine; oral
R01BA02 [21603210]
7.7e-01
1.1e+00
—
—
—
—
4.6e-02
cases:2.08%
controls:0.97%
cases:1.22%
controls:0.40%
—
—
—
—
—
—
—
—
cases:1.37%
controls:1.31%
29
133
1364
13522
17
55
1376
13600
—
—
—
—
18
167
1295
12585

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1084
8614
1.63
22.24
7.6
6.8
0.19
0.19
e9/l
0.17
968
7568
1055
8350
1.62
21.81
7.5
6.5
0.04
0.04
e9/l
0.43
928
7220
753
5519
1.62
21.24
6.8
6.5
—
—
—
0
0
1050
8336
1.60
21.14
7.5
6.5
0.59
0.58
e9/l
0.17
919
7205
1068
8530
1.60
20.82
7.5
6.6
1.90
1.93
e9/l
0.22
959
7543
972
7641
1.58
19.90
7.5
6.8
0.68
0.69
%
0.18
914
7196
971
7640
1.57
19.74
7.4
6.7
2.91
2.83
%
0.62
917
7205
971
7648
1.57
19.59
7.5
6.8
8.91
8.85
%
0.26
916
7211
986
7850
1.55
18.54
7.5
6.7
27.88
27.74
%
0.15
936
7483
966
7714
1.53
17.50
7.3
6.6
57.19
57.27
%
0.07
924
7410
1363
11846
1.58
15.92
5.6
4.4
10.86
11.56
mm/h
1.19
1297
11153
307
1905
1.73
15.83
1.8
1.7
—
—
—
0
0
1113
9305
1.49
15.19
10.4
9.9
4.14
4.11
e9/l
0.17
988
8127
858
6821
1.48
15.00
3.7
3.4
6.18
6.20
ph
0.21
465
3905
669
5078
1.50
14.61
2.6
2.3
193.29
244.93
u/l
0.84
634
4846
1401
12372
1.55
14.07
9.1
8.3
78.38
78.93
u/l
0.19
1335
11817
1184
10120
1.47
13.74
5.6
4.5
66.80
1849.85
e6/l
2.67
20
144
1118
9521
1.44
12.70
6.3
5.4
6.54
6.70
mmol/l
2.14
1066
9062
441
3143
1.53
12.68
1.4
1.3
31.37
28.02
iu/ml
0.28
148
972
881
7187
1.43
12.66
5.4
5.2
35.76
35.89
g/l
0.28
825
6777
673
5224
1.45
12.66
2.9
2.7
53.65
76.24
u/l
0.86
625
4880
878
7182
1.42
12.30
7.7
6.9
1.21
1.21
mmol/l
0.91
823
6681
665
5180
1.44
12.15
3.7
3.4
39.73
64.23
e6/l
0.51
505
3972
585
4457
1.46
11.99
3.5
3.2
0.34
0.42
e6/l
0.54
431
3264
1018
8584
1.41
11.81
6.4
6.7
11.06
11.73
umol/l
1.22
971
8221
743
5933
1.42
11.74
4.5
4.0
99.01
97.08
e6/l
0.02
530
4199
1000
8419
1.41
11.63
4.3
3.8
0.00
0.00
estimate
0.50
193
1755
1009
8516
1.41
11.52
4.3
3.8
0.00
6.92
estimate
2.31
200
1786
1010
8565
1.40
10.98
4.3
3.8
0.00
0.19
estimate
0.54
192
1653
953
8006
1.39
10.94
8.5
7.5
1.21
1.21
mmol/l
0.69
817
6964
617
4814
1.42
10.89
4.2
4.3
7.40
7.40
ph
0.33
448
3484
626
4900
1.42
10.84
6.4
6.3
—
—
—
0
0
50
176
2.89
10.79
1.8
1.6
48.65
59.34
%
1.00
31
111
338
2362
1.53
10.44
1.3
1.4
394.55
492.69
titre
0.57
66
498
474
3556
1.45
10.26
2.9
2.7
5.73
5.61
e6/l
0.07
436
3262
571
4432
1.42
10.25
4.9
4.4
—
—
—
0
0
426
3162
1.45
9.69
5.0
3.9
381.37
462.72
ng/l
0.23
327
2438
875
7350
1.36
9.54
11.7
14.2
1.17
1.23
inr
3.64
746
6101
331
2351
1.50
9.39
2.3
2.1
—
—
—
0
0
324
2295
1.50
9.31
1.3
1.2
—
—
—
0
0
885
7510
1.34
8.74
3.2
3.0
136.97
132.11
ug/l
0.23
829
7072
855
7235
1.34
8.54
12.5
11.5
0.00
0.00
e9/l
0.39
699
5957
553
4378
1.38
8.53
2.6
2.7
338.85
345.48
umol/l
0.84
493
3929
678
5550
1.35
8.42
3.2
3.5
2.34
2.36
mmol/l
1.69
622
5094
388
2904
1.43
8.29
1.4
1.3
15.58
11.53
u/ml
0.47
145
1166
375
2809
1.42
7.95
3.5
3.6
0.82
0.82
mmol/l
0.06
356
2665
527
4182
1.36
7.90
4.4
4.3
92.28
90.22
%
1.17
511
4103
297
2136
1.47
7.82
2.2
2.5
114.80
130.17
ug/g
0.25
244
1723
555
4458
1.35
7.65
1.7
1.7
18.70
20.12
nmol/l
1.62
467
3797
400
3050
1.40
7.62
2.8
3.0
524.09
532.62
mosm/kgh2o
0.31
353
2695
825
7021
1.32
7.61
2.2
2.1
94.46
95.99
pmol/l
0.41
449
3768
471
3698
1.37
7.49
1.9
1.7
0.93
1.15
mg/l
2.30
375
2843
484
3817
1.36
7.49
4.0
3.6
—
0.11
—
0
36
1659
15718
1.55
7.38
20.9
15.7
23.00
24.07
mg/l
0.69
1415
12942
60
285
2.14
6.97
4.6
2.5
—
—
—
0
0
366
2796
1.39
6.83
3.2
2.9
1.04
1.08
e6/l
0.06
182
1478
79
422
1.91
6.67
3.4
3.4
2.00
2.09
index
0.03
36
225
679
5718
1.30
6.46
3.6
3.4
34.15
36.17
u/l
0.28
657
5419
226
1602
1.47
6.38
2.4
2.6
41.10
69.23
u/l
0.44
197
1362
118
724
1.67
6.27
2.8
1.5
16.02
10.93
iu/ml
—
6
22
856
7453
1.28
6.18
3.1
2.8
—
—
estimate
—
0
0
262
1930
1.42
6.01
10.4
8.8
7.41
7.41
ph
0.25
149
1063
169
1145
1.52
5.94
2.3
2.5
19.33
21.23
au/ml
0.16
16
126
77
425
1.85
5.91
2.0
1.7
13370.70
12230.18
e6/l
0.12
61
289
550
4551
1.30
5.86
3.7
3.2
—
—
—
0
0
1683
16111
1.51
5.84
23.1
18.4
3.98
3.98
mmol/l
0.73
1663
15809
1679
16067
1.50
5.81
22.9
18.3
139.57
139.69
mmol/l
1.17
1660
15795
499
4082
1.30
5.78
2.6
2.3
2.72
2.84
mg/l
0.60
433
3520
259
1917
1.41
5.78
10.3
8.8
1.45
0.92
mmol/l
1.79
212
1595
260
1929
1.40
5.72
10.4
8.8
5.21
5.11
kpa
0.91
252
1864
260
1930
1.40
5.70
10.4
8.8
12.00
12.15
kpa
0.22
254
1866
88
512
1.75
5.69
1.4
1.4
295.35
280.29
ug/g
0.35
57
301
328
2532
1.36
5.66
2.5
2.6
2.39
2.32
g/l
1.37
306
2360
348
2714
1.35
5.62
2.6
2.6
13.41
13.28
umol/l
0.11
331
2539
398
3171
1.33
5.55
2.9
3.0
2.44
2.45
mmol/l
0.62
351
2883
242
1785
1.41
5.50
2.5
2.8
1.80
1.81
%
0.10
223
1605
331
2572
1.35
5.47
3.4
3.1
2.86
2.40
e6/l
0.20
146
1253
146
979
1.53
5.40
3.3
3.6
4.41
4.55
pmol/l
0.98
139
873
68
372
1.86
5.40
2.6
3.5
57.00
57.94
%
0.25
68
372
1331
12332
1.28
5.38
4.8
4.3
14.77
14.76
pmol/l
0.06
1244
11410
154
1048
1.51
5.32
1.3
1.3
23.41
56.56
au/ml
—
7
76
188
1337
1.45
5.22
2.7
2.8
65.22
66.87
g/l
2.23
174
1243
1422
13311
1.30
5.16
24.2
19.1
13.64
13.60
%
0.61
1407
13141
56
292
1.95
5.14
2.6
3.6
3.62
4.14
e9/l
1.14
56
292
826
7295
1.24
4.86
2.7
2.5
77.98
76.61
nmol/l
0.70
754
6655
457
3775
1.28
4.79
5.4
4.9
—
—
—
0
0
76
448
1.73
4.75
1.2
1.2
—
—
—
0
0
123
821
1.53
4.68
2.1
1.8
0.32
0.33
mg/l
0.07
68
417
129
871
1.52
4.65
1.3
1.2
—
—
—
0
0
107
693
1.58
4.65
1.7
1.8
4.73
7.27
iu/ml
0.72
21
162
281
2185
1.34
4.59
5.7
6.3
1.03
1.03
mmol/l
0.05
265
2035
454
3768
1.27
4.56
4.5
3.8
1.02
1.42
kg/l
0.50
296
2505
66
380
1.76
4.49
1.8
2.3
135.24
129.71
g/l
0.92
51
307
268
2077
1.34
4.48
3.2
3.5
4.38
4.96
e9/l
0.80
232
1820
318
2527
1.31
4.46
2.1
2.1
29.77
29.38
s
0.52
306
2453
185
1352
1.41
4.44
4.0
2.8
10.06
10.73
g/l
1.39
179
1256
79
481
1.67
4.41
3.6
6.9
1.30
1.30
mmol/l
0.02
74
425
1231
11416
1.24
4.33
3.9
3.4
49.36
49.98
u/l
0.09
1169
10836
450
3752
1.26
4.32
1.4
1.3
1.61
1.52
u/ml
0.04
131
1056
32
145
2.23
4.28
1.9
1.4
30.83
33.60
%
0.13
15
91
153
1088
1.44
4.28
2.2
2.5
—
—
—
0
0
251
1944
1.34
4.21
1.7
1.6
—
—
—
0
0
654
5698
1.23
4.21
3.4
3.4
7.79
7.86
mmol/l
0.15
564
4909
249
1928
1.34
4.18
2.0
3.0
7.50
8.01
umol/l
0.20
210
1703
294
2332
1.31
4.17
2.5
2.7
22.18
23.18
%
0.64
277
2190
172
1256
1.41
4.16
4.6
4.0
—
—
—
0
0
81
509
1.62
4.02
1.6
1.6
1.18
1.20
g/l
0.22
76
482
36
177
2.05
3.96
1.9
1.3
7.08
6.79
g/l
0.16
26
124
153
1106
1.42
3.93
1.3
1.3
—
—
—
0
0
210
1603
1.35
3.88
2.4
2.2
399.78
375.62
nmol/l
0.94
194
1497
83
533
1.58
3.79
3.1
3.5
32.18
46.19
mg/l
0.99
71
455
83
533
1.58
3.79
3.1
3.5
42.47
61.08
mg/l
0.80
71
455
703
6220
1.21
3.78
4.3
3.7
52.65
55.09
ng/l
0.04
471
4310
163
1200
1.39
3.78
3.1
3.0
118.00
188.86
ng/l
3.48
148
1097
94
622
1.54
3.77
1.4
1.2
—
—
—
0
0
59
348
1.72
3.74
1.4
1.4
—
—
—
0
0
96
640
1.53
3.73
3.9
2.0
—
—
—
0
0
356
2942
1.26
3.64
2.0
1.9
—
—
—
0
0
301
2438
1.28
3.63
1.6
1.6
—
—
—
0
0
35
177
2.00
3.59
1.9
1.3
0.44
0.38
g/l
0.31
25
122
35
177
2.00
3.59
1.9
1.3
2.53
3.01
g/l
0.94
24
122
189
1439
1.35
3.57
5.0
5.0
0.09
0.33
%
0.56
45
363
394
3302
1.25
3.56
1.7
1.7
69811754.39
29068534.65
pmol/l
0.47
318
2790
14
46
3.06
3.53
1.0
1.8
516.50
91.02
nmol/24h
0.44
14
46
35
179
1.97
3.49
1.9
1.4
—
—
—
0
0
51
295
1.75
3.48
1.1
1.1
—
—
—
0
0
100
684
1.49
3.46
1.9
1.9
—
—
—
0
0
27
126
2.16
3.42
1.1
1.1
—
—
—
0
0
179
1368
1.34
3.31
2.6
2.8
72.85
71.34
e9/l
0.24
140
1000
28
135
2.09
3.28
1.1
1.1
—
—
—
0
0
192
1487
1.33
3.24
5.7
8.1
9.33
9.54
mmol/l
0.16
182
1438
392
3316
1.23
3.23
1.7
1.5
2.36
2.46
g/l
0.44
248
2116
532
4642
1.21
3.21
4.8
4.0
0.01
0.01
estimate
0.07
196
1622
168
1281
1.34
3.16
1.2
1.2
—
—
—
0
0
51
306
1.69
3.10
1.9
1.7
0.94
0.79
g/l
0.38
39
240
193
1507
1.31
3.09
4.7
4.6
0.94
0.95
%
0.01
52
473
62
392
1.60
3.08
1.3
1.2
3.72
3.76
mmol/l
0.15
56
373
57
353
1.63
3.07
2.9
4.1
—
—
—
0
0
184
1429
1.32
3.06
4.5
4.4
0.77
0.69
%
0.18
50
437
8
16
5.02
3.05
3.1
1.8
—
—
—
0
0
185
1439
1.32
3.04
4.8
4.7
0.02
0.12
%
2.88
45
404
96
670
1.46
3.04
4.1
5.9
0.83
0.87
%
0.44
91
635
717
6453
1.18
3.02
4.3
3.7
0.00
0.04
estimate
4.84
171
1453
55
340
1.64
2.99
1.8
1.7
—
—
—
0
0
36
197
1.84
2.99
1.4
1.4
—
—
—
0
0
214
1704
1.29
2.96
2.9
3.6
7.38
7.38
ph
0.51
115
963
543
4778
1.19
2.96
3.4
3.2
1115.89
1182.95
ng/l
0.18
476
4067
83
568
1.48
2.91
2.5
2.3
10.15
10.44
g/l
0.28
78
515
98
693
1.44
2.91
3.8
1.9
—
—
—
0
0
145
1098
1.35
2.87
1.2
1.2
92.97
140.47
u/ml
1.43
67
422
72
480
1.52
2.86
2.8
3.3
1.78
3.27
ratio
1.04
40
272
23
109
2.12
2.85
1.1
1.0
—
—
—
0
0
98
696
1.43
2.84
3.8
1.9
—
—
—
0
0
206
1643
1.29
2.82
2.9
3.6
1.79
1.84
mmol/l
0.08
180
1418
30
158
1.91
2.81
1.7
1.3
116235.47
150033.23
e6/l
0.11
19
111
98
699
1.42
2.78
3.9
1.9
—
—
—
0
0
100
716
1.42
2.78
1.6
1.8
1.50
1.56
g/l
0.22
89
630
142
1078
1.34
2.78
3.1
3.7
5.17
5.16
kpa
0.08
134
1046
584
5198
1.18
2.76
2.7
2.5
—
—
—
0
0
18
78
2.32
2.75
3.1
1.5
—
—
—
0
0
251
2058
1.25
2.74
1.6
1.5
—
—
—
0
0
69
461
1.52
2.73
1.9
2.0
4.60
16.42
iu/l
0.46
22
186
306
2567
1.23
2.72
1.8
1.7
1135.58
1200.15
nmol/l
0.62
242
1969
47
288
1.65
2.68
1.1
1.1
—
—
—
0
0
133
1006
1.35
2.67
2.6
3.5
24.29
24.30
mmol/l
0.02
133
996
96
688
1.42
2.67
3.6
1.9
—
—
—
0
0
62
407
1.54
2.66
2.7
3.0
8.21
8.22
kpa
0.03
62
402
101
733
1.40
2.62
4.1
5.6
1.71
1.60
%
0.50
95
699
137
1048
1.33
2.56
3.2
3.7
7.41
7.42
ph
0.28
119
891
49
308
1.61
2.54
1.1
1.1
3.58
4.78
u/ml
0.25
22
168
92
662
1.41
2.52
1.2
1.2
0.18
1.01
u/ml
—
6
44
16
69
2.33
2.48
3.0
1.7
—
—
—
0
0
200
1619
1.26
2.45
2.0
2.3
0.20
0.21
g/l
1.07
185
1521
167
1322
1.29
2.45
1.6
1.5
—
—
—
0
0
186
1494
1.27
2.43
12.3
9.6
—
—
—
0
0
754
6902
1.16
2.42
2.1
1.9
1.34
1.41
mmol/l
1.39
632
5911
66
450
1.48
2.41
1.9
2.9
65.34
61.53
%
0.70
66
439
123
938
1.33
2.37
1.1
1.1
—
—
—
0
0
145
1132
1.30
2.37
1.5
1.3
204.89
215.93
u/ml
0.08
134
1053
86
620
1.41
2.35
2.1
2.0
20.04
21.03
s
1.65
78
559
57
379
1.52
2.35
1.4
1.4
5.83
37.21
e6/l
1.05
41
278
187
1511
1.26
2.34
2.3
2.1
0.00
0.02
estimate
0.78
30
326
19
92
2.08
2.27
1.6
1.3
142.63
142.86
nmol/l
0.01
19
92
519
4639
1.17
2.27
3.8
3.3
0.01
0.05
estimate
0.80
176
1395
1511
14600
1.19
2.25
5.9
5.3
1.82
1.90
mu/l
1.62
1420
13608
208
1710
1.24
2.25
2.7
2.4
15.07
13.81
nmol/l
1.22
195
1567
53
351
1.53
2.23
1.2
1.1
1.74
2.02
u/ml
0.12
25
189
46
295
1.57
2.23
1.1
1.1
0.25
1.67
u/ml
1.64
18
126
585
5284
1.16
2.22
3.2
3.5
42.10
48.79
mg/l
0.30
363
3425
16
73
2.20
2.21
1.4
1.3
—
4.13
%
—
0
15
52
345
1.52
2.18
2.8
2.8
90.38
90.25
%
0.05
52
336
57
386
1.49
2.17
1.4
1.4
1023.74
800.84
e6/l
0.13
43
295
120
927
1.31
2.14
2.4
2.7
1.52
1.26
%
1.05
120
922
34
205
1.67
2.11
1.3
1.4
0.18
0.27
nmol/l
0.51
27
163
137
1082
1.29
2.08
12.9
9.5
25.46
24.96
mmol/l
1.04
137
1077
103
789
1.32
1.97
2.3
2.3
—
—
—
0
0
16
77
2.09
1.96
1.1
1.2
—
—
—
0
0
155
1254
1.26
1.95
3.5
4.0
1.22
1.23
mmol/l
0.23
135
1095
1715
16825
1.27
1.93
25.2
20.0
76.40
77.58
umol/l
1.01
1700
16663
63
449
1.42
1.89
1.1
1.2
—
—
—
0
0
30
182
1.66
1.85
1.4
1.6
—
—
—
0
0
589
5390
1.14
1.79
3.8
4.2
7.88
8.88
mg/mmol
0.21
358
3425
677
6252
1.13
1.78
2.2
2.1
—
—
—
0
0
244
2093
1.19
1.76
1.3
1.3
—
—
—
0
0
135
1090
1.26
1.75
16.3
11.1
0.62
0.63
%
0.11
135
1082
88
672
1.33
1.75
1.7
2.0
0.96
1.77
ug/l
0.92
77
600
140
1710
0.80
1.72
1.5
1.4
—
—
—
0
0
139
1130
1.25
1.71
15.9
10.7
1.49
1.34
%
0.40
139
1122
48
681
0.70
1.71
1.1
1.1
0.78
0.67
ratio
—
6
78
94
728
1.31
1.70
2.9
3.4
25.27
25.22
mmol/l
0.06
88
699
76
571
1.35
1.69
2.4
2.6
—
—
—
0
0
8
31
2.59
1.66
1.0
1.1
—
—
—
0
0
24
143
1.69
1.61
2.3
2.1
22.34
19.95
nmol/l
0.43
24
133
17
92
1.86
1.56
2.3
1.7
—
—
—
0
0
32
208
1.55
1.54
1.9
1.2
—
—
—
0
0
76
581
1.32
1.53
3.2
3.9
24.37
24.86
mmol/l
0.82
70
545
5
15
3.34
1.52
1.2
1.1
—
—
—
0
0
32
209
1.54
1.51
1.5
1.9
—
—
—
0
0
161
1349
1.21
1.51
2.1
2.4
10.36
7.88
ug/l
0.35
140
1202
163
1369
1.21
1.50
2.0
1.8
—
—
—
0
0
13
65
2.01
1.48
1.5
1.8
75.06
50.92
ug/l
0.44
13
65
169
1991
0.83
1.48
2.0
2.1
3.62
3.60
ratio
0.07
127
1590
221
1912
1.18
1.47
1.3
1.4
—
—
—
0
0
54
728
0.73
1.45
1.1
1.1
1.60
1.51
g/l
1.78
54
728
66
499
1.33
1.45
1.1
1.2
76.67
99.22
titre
—
6
51
30
196
1.54
1.43
1.2
1.3
—
55.91
—
0
11
136
1128
1.22
1.43
16.3
10.9
93.49
93.74
%
0.17
136
1123
421
4618
0.89
1.41
1.5
1.4
—
—
—
0
0
24
149
1.62
1.41
1.3
1.6
—
—
—
0
0
93
741
1.27
1.40
3.2
3.8
—
—
—
0
0
23
142
1.63
1.38
2.0
2.0
42.73
38.37
%
0.56
23
142
21
127
1.66
1.36
1.1
1.1
—
—
—
0
0
31
207
1.51
1.35
1.3
1.3
—
—
nmol/l
—
0
0
30
199
1.52
1.35
1.4
2.0
12.05
10.95
%
0.61
30
199
93
746
1.26
1.33
3.0
3.6
1.02
1.02
ratio
0.13
87
689
1697
16704
1.20
1.33
14.3
12.0
28.32
27.59
u/l
0.26
1665
16327
20
121
1.66
1.31
1.2
1.1
3.60
2.93
nmol/l
—
7
20
31
209
1.49
1.30
1.4
1.4
282.80
278.31
mosm/kgh2o
0.44
20
159
590
5491
1.11
1.30
5.1
4.9
2.09
2.30
ug/l
0.35
540
5018
43
310
1.40
1.29
1.3
1.3
52.76
61.62
mmol/l
0.81
33
250
8
35
2.29
1.27
1.6
1.2
—
—
—
0
0
35
244
1.44
1.26
1.1
1.1
7.55
4.19
u/ml
0.25
14
103
23
147
1.57
1.23
1.5
1.4
—
—
—
0
0
41
296
1.39
1.23
1.1
1.1
2.84
1.31
u/ml
0.36
22
146
1385
13476
1.11
1.19
25.6
19.7
332.69
332.92
g/l
0.41
1377
13406
15
86
1.75
1.19
1.6
2.6
2089.33
1984.99
ml
0.18
15
78
124
1469
0.83
1.19
1.8
1.8
3.52
3.51
mmol/l
0.04
85
1057
24
157
1.54
1.17
1.6
2.3
—
—
—
0
0
52
394
1.33
1.17
1.2
1.2
—
—
—
0
0
23
150
1.54
1.14
1.0
1.1
—
—
—
0
0
629
6683
0.91
1.14
3.4
3.1
—
—
—
0
0
7
30
2.34
1.12
1.3
1.0
7.71
8.54
mg/g
—
7
30
92
756
1.23
1.10
1.4
1.4
31.48
27.83
iu/l
0.47
78
642
23
152
1.52
1.09
1.4
1.4
—
—
—
0
0
22
144
1.53
1.08
1.6
1.3
3.66
0.64
u/ml
0.55
17
80
26
370
0.70
1.03
1.4
1.3
—
—
—
0
0
13
75
1.74
1.02
1.7
1.3
152.62
181.89
mmol/24h
0.86
13
75
84
691
1.23
1.02
1.3
1.2
—
—
—
0
0
29
205
1.42
1.01
1.9
2.4
33.52
32.51
pg
0.77
29
205
1532
15030
1.11
0.99
6.5
6.2
38.93
39.24
mmol/mol
0.72
1451
14209
70
568
1.24
0.97
3.2
3.7
256.06
378.64
mg/l
0.52
34
266
7
36
1.95
0.97
2.6
1.9
2.42
3.34
mmol/l
—
7
29
154
1345
1.16
0.97
3.0
2.5
0.33
0.43
e6/l
0.45
147
1290
12
69
1.74
0.96
2.3
2.3
16.97
138.88
ug/l
0.51
12
59
42
320
1.32
0.95
3.6
5.0
2.56
2.58
mmol/l
0.02
30
208
9
51
1.77
0.94
2.8
2.9
—
—
—
0
0
8
42
1.91
0.88
1.6
1.5
—
—
—
0
0
35
263
1.34
0.88
1.1
1.1
11.48
2.56
u/ml
0.85
16
132
13
79
1.65
0.88
1.1
1.1
170.41
200.23
iu/ml
0.19
13
79
90
759
1.20
0.88
2.6
3.3
188.47
81.32
u/ml
0.34
84
733
55
441
1.25
0.86
2.4
2.2
4925.33
4576.30
u/l
0.03
16
177
75
623
1.21
0.86
2.8
3.5
198.85
2543.59
u/ml
0.86
65
543
40
308
1.31
0.86
1.7
1.3
13.67
31.35
u/l
2.11
35
263
31
232
1.34
0.81
2.8
2.6
—
—
—
0
0
43
338
1.28
0.80
1.2
1.1
—
—
—
0
0
43
338
1.28
0.80
1.2
1.1
—
—
—
0
0
139
1226
1.14
0.80
3.5
4.0
88.25
87.53
ng/l
0.03
117
1075
61
501
1.23
0.79
1.3
1.4
9.70
8.70
u/l
0.22
46
408
23
316
0.72
0.79
1.1
1.2
—
—
—
0
0
63
521
1.22
0.77
1.5
1.3
274.95
222.09
miu/ml
0.41
19
233
24
174
1.38
0.76
1.4
1.4
2197.94
1809.28
e6/l
0.16
17
116
6
34
1.77
0.76
2.0
3.1
—
—
—
0
0
1482
15056
0.92
0.73
4.5
4.3
1.36
1.33
mmol/l
0.74
1384
13986
15
100
1.50
0.73
1.4
1.5
12.80
13.51
u/l
0.19
15
93
71
599
1.19
0.72
1.6
1.6
13.48
12.30
u/ml
—
9
143
22
159
1.39
0.72
1.1
1.2
—
—
—
0
0
5
27
1.85
0.68
3.4
3.4
—
—
—
0
0
36
284
1.27
0.68
2.2
1.8
—
—
—
0
0
20
144
1.39
0.68
1.5
1.5
49403.70
27250.84
e6/l
—
10
77
31
240
1.30
0.67
5.2
6.4
392.12
365.12
umol/l
0.45
25
218
572
5458
1.07
0.67
3.7
3.5
—
0.79
—
0
14
15
103
1.46
0.65
1.1
1.2
—
—
—
0
0
26
198
1.32
0.64
1.2
1.2
—
—
—
0
0
20
146
1.37
0.63
1.2
1.4
185.42
233.54
pmol/l
0.31
20
146
72
617
1.17
0.63
1.0
1.1
—
—
—
0
0
12
79
1.52
0.62
1.4
2.9
45.83
139.24
umol/l
—
6
46
19
254
0.75
0.59
3.3
4.0
67.53
28.99
u/ml
0.36
19
247
17
231
0.73
0.58
1.6
1.6
—
—
—
0
0
33
408
0.81
0.57
1.7
1.6
—
—
—
0
0
27
211
1.28
0.57
2.2
2.8
—
—
—
0
0
12
81
1.48
0.57
1.2
1.2
237.00
411.35
u/l
0.65
12
75
11
160
0.69
0.55
1.2
1.2
—
—
—
0
0
173
1882
0.91
0.55
4.6
4.8
31.71
31.78
%
0.03
128
1279
15
107
1.41
0.55
3.1
2.7
47.43
43.01
%
—
7
54
160
1463
1.10
0.55
4.3
4.2
7.37
7.35
ph
0.62
125
1074
27
213
1.27
0.54
3.1
2.3
0.82
0.91
%
0.40
19
152
18
134
1.35
0.53
1.1
1.3
—
—
—
0
0
13
91
1.43
0.53
1.5
1.2
0.58
0.53
ratio
—
5
57
26
206
1.27
0.51
1.1
1.2
—
—
—
0
0
17
225
0.75
0.51
1.6
1.5
—
—
—
0
0
9
65
1.39
0.50
2.1
1.7
32.22
30.82
%
—
9
65
19
145
1.31
0.48
2.6
2.2
4.60
5.64
umol/l
0.31
11
102
15
110
1.37
0.48
1.0
1.1
7.08
7.98
iu/ml
—
5
34
7
48
1.46
0.46
1.0
1.4
—
—
—
0
0
1737
17261
1.11
0.46
30.2
23.6
250.39
250.21
e9/l
0.04
1712
16966
7
50
1.40
0.45
1.4
1.2
26.57
28.12
s
—
7
50
19
148
1.29
0.43
5.6
3.5
14.91
12.27
index
0.47
11
93
1737
17266
1.10
0.43
30.1
23.5
91.22
90.97
fl
1.47
1724
17109
9
127
0.71
0.43
2.2
1.4
83.44
79.55
umol/l
—
9
127
15
196
0.76
0.43
1.7
1.2
—
—
—
0
0
1737
17268
1.10
0.42
30.1
23.5
30.41
30.35
pg
0.75
1724
17111
12
87
1.38
0.42
1.2
1.1
1239.33
1627.99
miu/ml
0.55
12
87
17
131
1.30
0.42
1.0
1.1
—
—
—
0
0
1737
17269
1.10
0.41
30.2
23.5
4.51
4.54
e12/l
1.95
1704
16929
1737
17269
1.10
0.41
30.9
24.1
40.80
41.04
%
0.39
1724
17104
21
167
1.26
0.41
1.0
1.1
—
—
—
0
0
86
776
1.11
0.41
6.0
4.4
36.95
36.92
°c
0.34
86
769
0
15
0.00
0.41
0.0
1.5
—
37.45
—
0
15
0
16
0.00
0.41
0.0
9.4
—
0.22
—
0
16
1538
15228
1.06
0.41
5.3
5.0
5.94
5.95
mmol/l
0.05
1432
14130
14
105
1.34
0.41
1.9
1.8
93.04
107.43
ng/l
0.24
14
105
14
105
1.34
0.41
1.3
1.3
14.57
11.30
u/l
0.81
14
93
15
194
0.77
0.40
2.8
1.7
90.55
20.69
ug/l
0.42
15
189
36
306
1.18
0.39
1.1
1.1
4.57
20.44
au/ml
3.82
12
82
1737
17273
1.10
0.39
30.3
23.6
6.80
6.74
e9/l
0.44
1702
16925
8
61
1.31
0.39
1.0
1.8
40.55
41.22
g/l
—
8
61
5
35
1.43
0.39
1.8
1.4
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
44.78
55.69
iu/ml
—
5
35
16
204
0.78
0.39
3.2
2.5
46.70
46.88
iu/ml
—
5
24
30
356
0.84
0.39
4.8
4.7
—
—
—
0
0
5
36
1.39
0.38
1.0
1.4
—
—
—
0
0
1737
17276
1.09
0.38
30.4
23.7
136.04
136.86
g/l
1.46
1725
17120
78
861
0.90
0.37
1.6
1.7
—
—
—
0
0
5
37
1.35
0.37
2.4
2.3
—
—
—
0
0
27
225
1.20
0.37
1.1
1.1
0.16
0.30
u/ml
—
9
72
87
793
1.10
0.36
2.7
2.2
0.08
0.02
estimate
0.36
25
254
23
189
1.22
0.36
1.2
1.3
—
—
—
0
0
12
90
1.34
0.35
1.8
2.8
15.63
16.49
%
0.48
12
90
14
179
0.78
0.35
2.8
2.5
—
—
—
0
0
20
162
1.24
0.35
1.1
1.1
—
—
—
0
0
6
45
1.33
0.33
3.2
3.1
—
—
—
0
0
13
165
0.79
0.32
1.7
2.6
—
—
—
0
0
29
249
1.17
0.30
1.1
1.2
—
—
—
0
0
32
278
1.15
0.29
1.3
1.2
5.79
4.89
u/ml
0.19
14
120
42
373
1.13
0.29
1.7
1.9
0.79
0.91
nmol/l
0.55
35
318
27
232
1.17
0.28
1.0
1.0
1.38
2.06
eliau/ml
0.48
11
107
23
195
1.18
0.28
2.5
2.3
—
—
—
0
0
23
195
1.18
0.28
2.2
2.4
1.19
1.69
g/24h
0.37
16
120
10
76
1.32
0.28
1.5
1.7
—
—
—
0
0
132
1244
1.07
0.27
2.4
2.5
6.23
6.08
ph
1.07
91
820
12
150
0.80
0.27
4.3
3.1
130.41
34.62
mg/l
0.41
12
114
28
321
0.87
0.26
4.2
3.5
26.37
27.00
mg/l
0.03
21
225
29
254
1.14
0.25
1.3
1.2
—
—
—
0
0
63
579
1.09
0.25
1.4
1.3
—
—
—
0
0
26
226
1.15
0.25
1.7
1.5
—
—
—
0
0
26
226
1.15
0.25
1.7
1.5
—
—
—
0
0
26
226
1.15
0.25
1.7
1.5
—
—
—
0
0
26
226
1.15
0.25
1.7
1.5
—
—
—
0
0
12
96
1.25
0.24
1.5
2.6
6.57
7.99
mmol/l
2.04
12
96
0
11
0.00
0.21
0.0
4.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
38.00
—
0
6
0
10
0.00
0.21
0.0
1.1
—
0.13
—
0
5
0
10
0.00
0.21
0.0
4.2
—
105.80
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
0.06
—
0
10
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
11
89
1.24
0.21
4.9
7.0
2.57
228.11
ug/l
—
6
56
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
6
49
1.23
0.20
2.3
1.4
12.86
8.28
mmol/l
—
6
49
32
290
1.11
0.18
1.1
1.1
30.75
101.09
iu/ml
—
8
67
36
329
1.10
0.17
1.4
1.5
129.20
156.48
au/ml
—
5
94
15
129
1.16
0.17
1.0
1.1
33.80
16.99
u/ml
—
8
54
8
69
1.16
0.16
3.4
2.7
—
—
—
0
0
39
360
1.09
0.16
1.8
2.4
99.88
130.60
ug/min
0.19
20
217
8
72
1.11
0.16
2.6
2.4
118.00
152.32
nmol/l
—
8
63
172
1773
0.97
0.14
1.6
1.4
—
—
—
0
0
11
93
1.18
0.14
6.5
3.9
0.64
0.87
index
0.75
11
93
27
248
1.09
0.12
1.1
1.2
—
—
—
0
0
12
136
0.88
0.11
1.6
2.8
287.42
1183.29
mg
4.15
12
136
167
1630
1.03
0.10
3.9
4.3
53.58
21.11
ug/l
0.29
133
1334
5
45
1.11
0.09
1.2
1.2
192.40
293.14
pmol/l
—
5
29
6
54
1.11
0.09
2.3
1.7
0.50
0.06
estimate
—
6
54
5
61
0.82
0.08
1.2
1.1
—
—
—
0
0
5
62
0.81
0.08
1.4
1.4
57.40
59.42
%
—
5
52
53
551
0.96
0.08
2.7
3.4
1.34
1.50
mg/l
0.83
47
502
47
489
0.96
0.07
1.5
1.6
1083.37
1017.38
mu/l
0.20
40
402
8
93
0.86
0.06
1.6
1.5
7.58
6.64
ug/l
—
8
82
14
128
1.09
0.06
1.1
1.5
—
—
—
0
0
26
246
1.06
0.06
1.8
2.8
6.20
116.28
u/ml
0.96
26
241
19
178
1.07
0.05
1.1
1.1
—
—
—
0
0
14
129
1.09
0.05
1.1
1.1
122.79
105.90
pmol/l
0.58
14
129
37
357
1.04
0.04
1.5
1.5
—
—
—
0
0
1580
15820
0.99
0.03
5.4
5.1
4.63
4.66
mmol/l
0.44
1493
14911
54
552
0.98
0.03
5.9
3.8
1.39
1.36
mmol/l
0.11
54
540
10
108
0.93
0.03
1.0
1.2
—
—
—
0
0
136
1374
0.99
0.03
1.3
1.4
—
—
—
0
0
333
3345
0.99
0.02
3.2
3.0
0.82
0.72
ug/l
0.45
209
2011
12
127
0.94
0.01
1.3
2.2
1.57
1.70
u/field
—
7
77
51
504
1.01
0.00
14.7
9.7
—
—
—
0
0
15
155
0.97
0.00
2.1
2.3
—
—
—
0
0
37
365
1.01
0.00
1.3
1.3
366.15
260.44
u/ml
0.31
20
217
46
457
1.01
0.00
6.6
4.0
3.82
3.89
mmol/l
0.52
46
450
1575
15745
1.00
0.00
5.3
5.0
1.43
1.44
mmol/l
0.15
1475
14753
1602
16015
1.00
0.00
6.1
5.7
2.71
2.74
mmol/l
0.67
1497
15041
0
8
0.00
0.00
0.0
1.1
—
27.34
—
0
8
0
8
0.00
0.00
0.0
2.4
—
156.75
—
0
8
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
52
0.96
-0.00
6.0
1.9
—
—
—
0
0
8
89
0.90
-0.00
1.4
1.2
8.37
9.52
mm/h
—
8
89
0
5
0.00
-0.00
0.0
2.2
—
36.40
—
0
5
5
53
0.94
-0.00
1.0
1.3
34.00
29.44
%
—
5
48
6
67
0.90
-0.00
3.0
2.2
296.50
746.27
e6/l
—
6
55
6
67
0.90
-0.00
1.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
1.4
1.4
4.40
2.32
%
—
5
47
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
4.50
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
3.74
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint M13_DEFORMACQ and mortality.

Females

Parameter HR [95% CI] p-value
M13_DEFORMACQ 1.497 [1.27, 1.77] < 0.001
Birth year 0.992 [0.98, 1.0] 0.09

During the follow-up period (1.1.1998 — 31.12.2019), 190 out of 2352 females with M13_DEFORMACQ died.

Males

Parameter HR [95% CI] p-value
M13_DEFORMACQ 1.264 [1.1, 1.45] < 0.001
Birth year 0.988 [0.98, 1.0] 0.018

During the follow-up period (1.1.1998 — 31.12.2019), 368 out of 4323 males with M13_DEFORMACQ died.

Mortality risk

Mortality risk for people of age

years, who have M13_DEFORMACQ.

N-year risk Females Males
1 0.096% 0.246%
5 0.765% 1.58%
10 1.988% 3.958%
15 3.955% 7.455%
20 7.11% 12.602%

Relationships between endpoints

↥

Index endpoint: M13_DEFORMACQ – Other acquired deformities of musculoskeletal system and connective tissue

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data